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Abstrac t of {Jissl'rtat. ioo 
Thi~ s tudy w~ s c~·nd;;ctcd in an att<!mpt to ck fi nc the :•n t i i nfl cr-.~ta\orr cffic&l")' 
of cryogcr,inc : t h<: i'lil j=>r alkrtoLi o f Be i:.li ::. $.:ltic ifcli;.• l. i.nk <lrad Otto. ·~he ~nti.in ­
fh•:-.matory e f fects J'Tot!utec.! i:>y ·: l)·o!(cr.::li,- l'r.~tiy li)u-Ln7.?ne, ir11 . .ic••••etha<.:i n, rcu: fcnamic 
acid , il '" rat·.~ th asGnE' , 11ydrocort i sonc :!!Ill 1:-mcr c:lpt<Jp;; r inc IICTC' c·ov:pa n.:,! cor.s i c!eriq; 
the 5equcntial ch3n~cs in various ~ot nmcte:s during tnB cnurs~ of adjuv~nt-ind•~cd 
pv l y:~1·thriti s i n rr,t~. Po l)' 2:·thri t i s ;,·as i nd:.:cl'c'. by the sul.f. l <~;, tar injection of 
a suspC'nsic.n of he at a}. j llcd !-!ycoh:lc t ,.; ri ~..·m h ut}' 1·icwr. u t r.i nc r;jl C"1ij lnt J th~ r igh t 
hind paw of Spr'-'c:Jc - O~·•Iey :ii-;:- ·iiic.niril,'i 'fcs·t·atfo-n·s of t h(. <.ii.<r.::J.s .J •. c\e nHm~ tcncd 
in t erms of hind pa\·; s w\! llinr., $ul.J ject"vc· "P1Jcrn·anCl' l'f sccon'~ "t'." lP.sions , ir.~pa!.7"·· 
men t of body grol>th, «nc vari<Ju5 hcMatolo,r, i c:d/~.~ ro l CJJ:i·; :o l ch .1ngcs. l:ffc-~ts p;·o)-
d\:ccd 1:-y n·tor.cn i nf! i n j:Jn& lia and a cute card\ovascul.:n intt;r<cticns wit r. 'J;;r ·;ou~ 
:!lc·diators o f in fl'irLit~ tic:n aiH.i vaS\.' ac t ive agent~ \. e r e .Jlso in ·:estigc-.tcd in the ra t . 
11-.e efficacy of o :t<'f~l·ni nc in ·Jclaying u ! t ~·;,v iol ..: t - indu;:<:d t'l)'t ilcm~ .1nd dr~r.·· 
i nduced bronct•ocor:s t nc tiClil i n the gu inea pi g was dc t..: rr.. ~n<·d . kcsu!ts shoH•"l 
cryoi:cnin!' t<' b;, effective ir: suF prcss ing t !u: dc·t~JIO (I~:cnt c•f ;djuvanl-induc.-,J 
11olya rthri t is_in dos .~~ which appt: :n ·ed to !JLdc~:oi tl of a ~or toxi c r.~ani f cs t at ions . 
C!"YOJCI: inc •·as effectiv;; in pcr:r.it t\ng ~ pa rtial n:s~orJ.t i o r: of the noma! !·a t.: 
of bo;ly we ight !(a ir.. TI1e thl)rapeu ti c effects .~f. cryogea i11c in adjuvan t-Lij l!~t ed 
3njmals were reflected in a l 'OOS t nom!\ I l yrnJ,hOC'yt c/ncut r ophi! rat.1os t " <in~~ ­
trcated an i r>al s . Horcove;-, cryogcnine suppr<:'~ scd ac!n:nccc.rt.i c a l over~ eli vi t y 
as eviri~rtCt:'d hy ncar not;.tal thymus and ad renoJ w.zi~.h t s . C1·yo;~cnine tiarkedly 
inhibited inc r c.•s l'S in sc\J.i.mc·nt2tion ra t e a.nd dl·cr~asc~ in ~cn\!11 tvrt>i d it_y. 1hc~c 
studies have shc•;n crror.~·nine t o possess r. i gni fi e an t ant icrythc'li c <:c t ivit )' , but 
to be ineffective in inhibiting brad)·kin i n- , hi staminr: -, aw l 5c rotoni n-inJuccd 
bro:ho - constrio:t i on in t nc guinea pig. Cryoy,cn inc ~>as cs!."ati:~l l }' .Jcvni d nf ~ny 
ga~clionic act l vitr and rroduced no effect on rcs t inc ~l<Jnd pres sure or on c ardio -
vascu l a r t·cspor.s~s to epinephrine, a ce t r l cholinc, hist:L·.;i nc, or bTa~;tkinin . 
Alth.,ugh cryogcninc is struct urally unN ! a:ed to z.ny k••n1m d:J.~5 of a•ltiw flam-
matory, 2ntip)'retic or analgesis compou:1ds , it il as llc•:H shv-.,~1 to b'< e f fe.:tivc 
in scverol cxpcrir.1cntal inflan"natory conditions •,;h ich respond t o the antiinfla:n-
matory d·c\1£5 pres ently in c linical usc. Its non ~pcci fie i t y of actlon ar.ainst 
ncuro- and tissue ho r mones suy,gest that its :~ntiinfiacu;~a tory ac tivity i.5 not 
related p1·ima r i ly to inhibitio n o f acute phase r eactants c r l o peri pheral ncu ro-
trcpic ~ffccts. Involveme nt o f the pi tu i tary-adr..,na l axis i!o t he t hc::-apcutic 
efficacy of cryogcn ine seems imp r obable. 
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kfeim_~. _s;_~-~.1.-s_i.fo~-h.~ Link and Otto ( f a:r: .i.ly Lythracea.e ) 
is a relativel.y small shrub 1 0 . 5 to 3 m in r . e i gh +.:, qrm•Jii~g 
general ly .i.n mois t art.~a.s and i ndigenous to a. ~.<Ti de J.y 
dispersed a r ea. ex·cending- frorn I11exico to the bor d<·:::r :> of 
Argentina , includ j.ng Uruguay,. Pa.raguay and sou.thE::n~ Bra.z ~~ l 
(1) . Some confusion has e xi.s_ted a::: to the taxoncm:J.c s t atus 
of t h e genus !lei._!Ei~ because . of va.r:Labili -t.y :!..n ti1e <.;.lkc.loidal 
content of th~ p l ant e Several inves t i gators accept the 
found in the northerr: r ange (l\1exico) ct:nd .tf." .!.!}Y.E_~L.fclt~ 
occu1:-ring as the :;ou thern s pecies ( A;:·gen t:i.na) . ( 2) .. This 
distinction, however, is not universally accepted ~ More-
over , a recent co~parison of the alkaloid spec t r a in the 
two specie s has shown them to be essentially identica l; 
this is in accord wi i:h the s uggestion b y other authorities 
that .!:1e imia is a ch: a :.ly ~ mor-.otypic 9enus . The var iability 
in alkaloid distribution in the two species has been 
ascribed to c l imatic or other enviro nmental variations . 
i 
The plant is known under numerous common names includi ng 
"qu.J.ebra arac1o'' ( plO'I'!- b!'eaker) in r'l.rgentinC:J. 7 "c>.bre - .:>- S O]_ 11 
( s un-Ot)ener ) :Ln the Rio Grande de l Su.r , 11herva de la vida 11 
(hero of l if .. e) in Braz i 1 and "s.ini cuic;-d " ( h1is ted foot) 
• M • 
.:.n 1 ex:.:..~::o . 
'J.'he folklore assoc.:i_ated wi 1-.h t:hs u.se of i:he p lant is 
of special in t erest . In I"iex ico 11 sin.icuichi 11 is applied 
both t o the p lant and to a ferment ed decoction p~oduced 
from its l eaves . Bl omster et al . (3) and Tyler (4) have 
presented a summation of numerous ci tati o ns describing the 
us e ar:cl interest'ing effects attributed to " sinicuiche" , 
the " magic drink causing obli vion . 11 " Tl:.e dr i nk i s p r epared 
by macera-':ing slightl y wilted leaves in water: after wl'.ich 
t he jui ce is strong l y e x pressed , allowed t:o ferment , ar. r.:! 
c1.3.rifi~-i J.n the s:.:n" ( 4) . " :Irr.bib:i. tion of ~he bever_age 
p~oduces a fee l ing of g i ddiness , a mi l d s tupefac t ion , 
l ·as s i tude c:.nd a sensat:~on whereb~f t:he surroundings b ecor:1e 
darker , and the wor l d bec omes infini te ly smaller . Voices 
of t hose nearb y , t~e ~inging of bells , and o the r s ounds 
r seem to come f r om gre at d is tanc es . The d r inker seems to 
h ave a di s tort~d sens e of time and place and is forgetful . 
It is s t ated t h at he o f t e n re tells of ear l i er events as if 
t h e y had j ust taken place . The whol e state is charac terized 
as one of p l easant drows i ness . No ' hangover ' o r other 
detrimental effec t is noted t he n e x t day . The s i ng le 
abnormu. l s ymptom acc ompanying ov e r indulgence i s a pecu l i ar 
yelJ.ot.·J vision . Although habi i:ual excessi ve '..lse of 
' sinicuiche ' i s a.pp3.ren t l y de triment<J.J. to t.h<::: memox::z- , j_ ts 
users are said to be able to reme~ber, with gre~t cxacti t~de , 
happenings and experiences of t heir remote pastw In some 
cases, events which took p:ace befor e t he bj.rth of the 
individual , but. e.xperienc~d by hi s ancestors, r.tr·~ 
supposedl y rec2.ll ed " (3) . 
In 1958, Hegnauer and Herf st (5) confirmed the 
occurrence of a ppreciable amounts of .;llkaloids in the leav-es 
reported the iso l ation of five a lka loids from the plant, 
which were designated lythri~e , sinicuichine , ~eimine , 
sinine , and cryogenine-f.:. . 'l'he follmd:r:.;:r year t•:JC add:L -t-.ional 
alkaloids , nesodine and lyfoline, were isolated and 
purified from H. salicifol~~ ~y Appel_~~~ (G) . 
~ Chemical s tudie s conducted bv Ferris et al . (21) 
concerning the Lvthraceae pl~m t fa;nilv-descr:i.1)ed the 
isolation of certain aJ.l<:alci ds fro.~ oE:cc·don ver t i.cilla tus . 
'After· the isol ation and pur2.fica. tionoft:'1e &J.ka.TOia s·--
of Heimia saJ..:ci:foli~ haci. been n;!ported, ::>2.;ni l a.rities 
between these b ases and those isolatE:d f.rc;n Oe(.-:odon ,,,ere 
no t P_d ( ':1 ;' . =' l c1ns.._e,_. e ·t a 1 es .... a 1-,J J. -- ~1<',.., +·1.-.F• -;;:;;p·-:,:-,.. ;ca1 
- ..J L..> • '- - .l· ·- --=-. :_.~ .... . .... ') .. :..\...:. - 1:. ..... ~ .. ,.l~ • • ··'- ..J.,. • ..... 
formula for cryogenine and pointed out its near 
equival ency \d th vertine, isola ted from ~-~££!:~ 
ver tici lla tus_ by Ferris . Subsequen·tly , Za.cha.rias _et 3~:1:. · (22) indicated that vertine was identical with cryogenine . 
The chemical struc ture f or cryogenine (ver t ine) has since 
been proposed (23) and confirmed (24) . Fur ther more, it 
shoul d be noted that cryogenine (.NVJ ~ 435 . 5 3 ) 'J the major 
alkaloid is o l c.ted from I-!eimi a salicifo:ia I...ir.k and Otto , 
is not the registered t raden<J.me product Cryog-enine 
(phenylserr.icc_rbazide , (!'-Ttl = 151 . 2) a special ty of Lwr.i~re 
o f Lyons , France , and d is tri buted b y Laboratoires Sarbach 
of Ch~tillon , France . 
Dt.:r:'i.ng u .r: ~c:ent ls.:..lc.ticn of crycgE!::~ne for pharmaco l o:;J .:.c 
' • ~., .. ! ~ ·:- ::') t . .., : t c I c • . l. .l. -·'-' lOT 'i ·.1.1 f~:i.']i · ! ·i:h a.lka.lo:~d was i soJ.a tee! from the 
p lant and n arneJ. heir~1.idine ( 7).. The b 1ow:-1 s t!"uc tures o£ 
four of the o.lkaloids are illust!.~a i:ed :Ln F:!.gure 1 . Bc:•sed 
C'n c<.".r . .... '- ""•"'-~ ..... - ~~v_. +-.J-. ::-c __ +-·: . c)r.l +-ec11"'J. q " e'" crycge r1i !l"" co ..... +-e-- t 1. ~ 
- '-- <:::: - - '-· - '-- ~ J ~ • <..o. • i.:l ' • · • - ··. G ' u '- l. . J! 
+..:he d.r:ied over<J.:cound pl::1.n t. approximates 0 .. 035% (8). 
The uses of t~e plQn~ in f olk medicine ar e numerous 
and diverse . In Brazil 1 acco rding to Penna (9) 1 the plan-e 
finds use as an an tisyphilitic, an insectici~e, a general 
4 
depura ti.ve and as a sudorif ic . Cal deron 0.0) notes that t he 
plant has b een used as a c u r e f or dysentery and indiqes tio~ , 
..; ., 
..... t. the treat ment of 0ror.c: h i tis and other chest ailments a~d 
as c;-.n app etite ::;tir.1U:i.c:>.n·i:: . The plant is also ·~tsed b~r ~Jo\r.en 
for inflamma t ion of the ii'/Omb a.nd a.fte::- de livery t.-:• "clo:: e 
the womb ." I •,'I "'X • c · . . . n . · , . ~ .r.: .., 1 . ··· 'h r> .., -f' ' r .n. 1 e l 0 7 ~-:!:.:.t.:..l2;_ Sa .t.lC_-.:.~:..:.2.:..S:. . , _..., ~OUrt Cl 
spread use in loca-l medicine- because of i i:s repu-ted 
hemostatic , diaphore t ic, diuretic , purgative and astringe:'1t 
properti es . In addition~ u.n infusion of the p l ant has 
found utili ty in facil i tating the healing of ulce~s and 
as an antiin£ la.mma.torv in 1'\l'nls derm;::~.tit:is (11) . 
. --
In 1960 , r e sul t s of a preliminary pha rmacolog ic 
ev-alua·tion of extracts con taining the total al)(aloids of 
!!e:_imi_a salicifolic. an<i of purified crycgenine , i tself1 
indicated that cryogenine mimicked qualitatively and 
quantitatively the acti ons of t he total alk aloidal f=action 
of the p l ant ( 1 2) . In both unanesthetized rats and dogs , 
cryogeni:1e produced a quali ta.tively unique central ner:vous 
system depressant action char.acterizeJ by a reduction in 
C .. f·"y() ..... ~-· . fl ' . r--" '< . (j 1.::. i\l i I 'j t:. 
g 
,.....~ 
""-('+0 ' L~·, . I ( l'tl J:il 
r'!( ~,)) ~J OH 
CH~O I 
v OH 
L YFC)L I f\lr.:- L' "' _1.. I ,-, I > ' ,..... "~' I ; .... ,_.,, · •\! ;-1 1 ! 1 • II '--· 
Figure I.-- Structurally defined alkaloid::> of He.imia Salicir'olif!_ 
5 
6 
r.1otor act:l.vi·cy , g e:v~.:::- ?.1.1 passivi ty a nd mile! hypo therrn j .a . 
CoupJ.ed ~·!i t :-1 thes 8 11 "L:.ca:1qui.lizin9·" p.roper:ti es t:here '.'l.'t:t s 
"little evidence of ataxia, muscle dyscoor d i .na t ion 1 
analgesia , blepharopto sis anci mu0c:le .r e l a.xa.tion v Nei. t he !.:-
convulsicns nor park:Lnson-·l ike tremors wer:c n oted ai:: J.etha.1. 
dose levels . In addition, no apparent al teratio~s in 
resting blood px:-essure were obse rved in a n es t hetized .:Jogs 
.and ca t s . 
On i solated smoo th and skeletal muscle preparations , 
c rycgenine acted as an antispasmodic blocking acetylcholine-
induced c ontractions in both f r og E:=.s..~~ and ile-L1.l~l 
preparations (guinea p i g ., rabbit ) .. Subse:quen t k inetic 
studies indica t ed the a l kaloid to .be a. ,-~cm.conpe-ti. tivc: 
inhibitor of acetylcholine (13) . Attempts to protect 
agai nst both electrically- or p ent y len2tetrazoi- induced 
c onvulsbr-e s e izure s were not success"fu l 1 although c!:'yogenine 
appeared to significantl y delay t h e •:)n.se t of dea.th in 
~entylenetetrazol-i~jected rats . The results of this study 
a l so showed that cryogenine would b lock nervous conduction 
i n i solated frog sciatic nerve only at relatively high 
mol ar concentrations . 
To explore and corroborate t~e psychotropic potential-
ities suggested by t h e bizarre fb l k l ore , rats were subjected 
to various models o f conditioned avoidance-escape behavior 
(13 ) . Cryoger..ine at relatively low, nonataxic dose levels 
was shovm to selectively suppress "an."'Ciety" in both 
discrete and continuous discri mir..ati ve and nondiscriminative 
sj_tttc:i t l.ons . A cor.ls ide.rat.i.o11 of these rest1l t:s t·.og e·ther 
wi tt: the lack o f s erious side effects (hypo tension , 
skeJ.etal n U3c l e i nvcJ.vement ,. E')~b7-:lpyr.a.midal effec:-::;~ ) 
produc:~-:!~.~. :!:;y t h e alkaloid indica. ted c.ryogeni:i-1~: ·:::o be"! 
q u aJ.i. t:a1:iv.ely u.n:Lq:ue rt:~lat.iv-e to ~:he pre.sen t: cJ.:l.ni.c;:tJ.~.y 
empl.oyed tra::!.qt.•.iJ.izer.s (v.rh en such corr.pou.nds ar.2 B.m.1i.nistered 
Hhen s uFfi c ient quanti l:ies of the other purr:: aJ.ka l.:):i_ds 
(14 ) init::lated a comparative phu.t'rllr).Cologic: ~.;tudy cxf the se 
alkaloids with cry ogenine . Gr oss observational screening 
in unanes -t:hetiz. ed :;:·a ts confirr:1ed ec>.rl:i_er s tucUes of the 
qua l i ·ca.ti.ve symptorna toloqy produced by cryog~~nine.. :•:...·y thrine 
hydrochlox:-ide , he:imi.ne and Jyfoline .!:)ase ~.; 'II '?...;:· e. :folmc t o b e 
i nac ti:·v e except a;:: lethal des a.ges . Nesodine appea1:ed to 
p os s es.:; some cryogenine- like sedc>. i.:ive <J.cti v:i. ·t y 1 .out on ly at 
r e l a.:tively h i gh d0 se: l evels .. I n cardiova:=;c.u:La.t: st;Jc..ii.es in 
int-.act ari.e s theti zed dogs 7 both cryogeninf.:: ar1d nesod:i..ne 
a p peared t o inhibit the pressor effects pr.od1..!ced by exoge-
n ou sly ad!Tiinistered E·pin~ph:c.i.ne, hcn·Te\r;::r, kinetic ~;tvdies 
u t ilizing r at ~ d§/er_en~ de!l10nstrat.ed an apparent lack of 
speci fic i t y for adrenergic receptors by both alkaloids . 
One i nteresting obser~ation was the facilitation by 
cryogenine of smoo th mus cle contractions produce d by 
serotonin on is o l ated rat vas deferens . Addi t i onal isolated 
- ... - .- ·· ... -
smoo th musc l e studie s <.ier:1ons t.:::-a ted the noncompetitive 
antih i staminic , a n t i muscari n ic 1 and a nticholinergic 
8 
properties of cryogenine. In addition1 cryogenine a ppearect 
to possess little or no cholinesterase inhibitory activity 
{ . .. ) 
'\_L5 • 
In 1966 ~ in a comprehensive eva luation of the 
pha.r.:n;CJ.cologic actions of numerous plants used as local 
(16) confirmed the central nervous 
sysLem depressant propertie s p r oduced by ~thanol 8Xtracts 
He further noted a significant anti-
iLflarnmatory action produced by extractives of the plant in 
bno separate models of inflamrna tion ( yea.s t-ir:.duced foot 
edema in the rat , and cotton pellet granuloma in the guinea 
pigu This confirmation that cryogeni~e might be a new 
cherr.icaJ. prototype for antiinflv.mma.tory ac Ci vi t y intensified 
ongoing expe.rimen ts at The Uni versi t.y of Connec ·ti.cu t by 
Kaplan and c:o-\vorkers , and these s ti.ldi.es 'llere · ou:::; lished in 
1967 (lS}u Cryogenine was found to be p a rtially effective 
in limiting the inf l ammatory responses induced by plantar 
inj ec:ti.on of mycobacterial adjwant and was found to have 
signifi.cant antiph l ogistic act~vity against carrageenin-
induced pedal edema . Cryogenine also demonstrated a low 
order of analgesic and antipyretic efficacy. Evidence 
from several preliminary testing procedures indicated that 
cryogenine pretreatment afforded significant protection 
against serotcnin-induced pedal edema in the rat and 
histaminA-inducc:d intraderm2.l wheal responses i n the .!::'ab}:)it . 
Noreover , the results of several in Yi:!:£.9. investigations 
(isolated gu!nea pig ileum) demonstrated that cryogenine 
c oul d antagonize sever a l suspected mediators of inflammation 
(br '-'dykini .. n , histamine , serotonin) . !?c::.r.:tJaJ. r eversal of 
h1.s tamine antago!·J ism v..ras effec ted by l.ncreas i ng cone.: en ti· a -· 
tions of the a g oni st (1 5 ). Some li.mited specificity fo~ 
the h i s taminic recepto r 'l.r<:ts confirmP.d i r! subsequent. s tudies 
(17) . 
Moreover , var.cular srnoot.h ffiils::lE'~ cons tr.iction 
produced by oxy tocin and l=al lidi~ (iso la ted perfused rabbi t 
ear vein ) h as been reported to b e ;:-evE:rsibi.y :i.nhibi ted by 
rel~tively small concentrations of cryogenine (18) ~ 
Cryogenine has been reported ·t:o lack f'ibrino l ytic activity 
(15) . Rec ent testing has shown the alkaloid to be 
ineff'ective in reve;:-s ing stress--induced hyperglycemia l . .... ' . 
r ·ats (J. 9 ) . Unlike rese.r:pine or tetrabenazine·,- c:~ycgen:i.ne 
does not depl ete e i t her central or periphera l tissue levels 
of norepinephr ine a nd serotonin (20) . Histopathologic 
evaluations of the e ffects pr oduced by chronj_c:ally 
administer ed c ryogenine on various organs a n d tissues 
revealed no apparent lesions at antiinflammatory dose l e vels 
(15 1 20) . Thus , the antiinflammatory activity ascribed to 
cryoge~ine would appear to be unrelated to any systemic 
toxic rnanifes t a tion of the drug . 
An evalua tion o f data gathered from previous a nimal 
stud ies r eveal s that cryogenine incorporates several 
proper ties classically inherent to most clinically-emp loyed 
antiinfl ammatory agents (sedative , antihi staminic , and low 
orders of analgesic and ar..tipyretic activity ) . The p r esent 
study was undertaken to e x amine mor e thoroug hly certain 
aspects of t he pharmaco l ogic nature of cryog 2nine (other 
th~1 its psychotropic attributes ) and to compare its 
ant iinflamma-tory pote~1tiaJ. ~tli th k:10wn an tii.nflarmna tory· 
agents . Hopefully , interre la tionships between the effects 
observed in thi.s inves t i ga t:Lon cou l d lead to <i deli:1ea t i on 
of the possib le mechanisms res pons).hJ.e for t he u.n:Lque 
antiinf l amma.tory ac tivi i.:y attributed to cryogc::-d.ne . 
10 
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MATE RI ALS AND ME'I'HODS 
Adul t female rats o~ the Spr ague- Dawl ey strai n 
v:ei.yhing approx:i.Ir.ately 200 ~l were err.p loyed in al l 
0Xpnr 4 r~o rlt~ r)n arri··,~ l ~ nima·L~ wp __ ._r_A_. ~ • . CJ'tl~ P.Cl' ~n n?.ir·.~ 
..... <..: ~--1- ~~ .. \ .. .... v. ' ~ -"' . • J .. ' ·--- - .... - - .:;; 
and c. l l0v1ed to accJ.im<l1:e to t he ne~:,r env~~...r:-onmen c. .f or. c.l. 
per i od of r.o t l ess than one week prior t o r::~xpe~·imen ·:.::..--
tion .. - 1\mbient temperatures were mai ntained at 73 - '76 ° r-r-.. --
.4.11 ani mal s were offered a diet of commercial l y p.1::-epcl.?:"ed 
food 1 pellets- and tap water _ad l ibitum . 
") 
Heat- killed , des sica ted Mycobacterium E?.!.~.:t't!:;)-<.2.,~~~-
was s u spended in lig h t mi neral oi l ( USP ) ( Smg~nl ) wi t h 
~ d h . 3 a dan · "omogenJ.zer-. This sus pe nsion wa s sterilize~ in 
1 Purina Rat Chew . Crude protein not l ess than 30 . 0 %, 
crude fat n o t !ess than 4 . 5%, crude f i ber ~ot less than 
·6 ,. 0~:~ , ash r~o t less tl-1<-ln 9 " 0%, plus ~t .i. -tar.~in and mineral 
2 supplement .. Di fco Labora tories , Dc t:.::o:L t , Michigan. Catalogue 
3 number 0640- 33 . Kontes glass jackete d t issue homogenize r , Kontes Gl ass 
Ccmpany, Vi neland , New J er s ey . 
a n ri\.i col:: l i-:1 v e ( 20 pounds pres suo~ f o r 20 nd.nu tes) <'".Llv.~ 
i n j e c ti o:1 " the 11 a d j uv e.nt" \va . .s ,,, .:-:>. rrhe~J ~:; J. J.t; h t.l~{ t.o abov e 
s ub c u t .a n·::-o '..!S lnj ec t ion o i- () ,. 05 !P l. o f i:h e f ine :L·_y ·C::.c :i. tu::-~ a t e d 
t he le.ft 1·d .n d pa•tJ . .R.ats \vere L Lrst l is(ntly ;:,_n es·E:he!:i zed 
\\•it.h sod ium pent.ob ar b J.tal (3 0 rrH~J;<g :f ... p .. ) t o er.\S'..!r: e 
p r ec;i s.i..on in t he pJ.a c:e:me n t o f the . .. . . J.l1J e c~ ·::.1. tJ n. ~ 
Tnj ec t i c.:'"lS wen :! made using l in,-.: h 23 g aug e s t.er i l(~ 6 .:. s -
· · ~ . , l d . d . ') 0 1 'J • t p o ::; at:· J..e rt...::;ea .... es-- a ·· o.p r.e ·co 2. ,_ ., L m _ c a.pacJ. cy m.1.c rome c .r_· 
syringe-~ .. ·:ro e:w o i d e xte.x·na J. J.e a.k age o f the, a.d. j uve>.n t 
mixtUl.~e , t h e hypoder mic ne e d l e was i ns e rted -thron~:; h t :·w 
radi a l f oot QEd a nd ....directed medi a l ly into- t h e rnet-at.a:r:·saJ.-
region , keeping t h e n e edle channel as ne ar to t h e skin 
s urface a s possib l e t o minimize t h e po ss i b ili t y of vasc ula r 
invo lvemen t . 
P.r-ior to inj e ction o f the a djuva n t , t h e r a.-t s were 
r a ndomly divided into g r oups o f 1 0 animals e a ch . Eac h 
stu cy i n c lud ed 2 c ontro l g rou ps : a "pos i tiv e ~on t.roJ. " 
g r oup \vhi ch .r- e cei v ed a djuvan t b ut no drug tr e o.t;nent. , und 
a "ne g a U.vt=-~ c o n t rol 9 .:-:·r)up '! of : 0 a nimals r e ceiving n ·::d t h e r 
l 
2 Be cton , Dicki nson and Company , Ru the r f ord , New Jers ey ~ Rog e r Gi lrnon t I ns t.!:"ume n t s 't Inc o l Gre c:t t Neck !<oad 1 
Gr eat ·,\fed,: , ~;,:;;v Yor:< .. : a t..::.. l O'JUe numb e r S 1200 ., 
1? 
..... ·~ .... 
• _, l .. 
For each dr~g eva l uation, 
2i1:Lmc..ls 
l '1 
' . J 
All dr ugs undergoir:q tes ·t. \\-'ere dissolvec! o.r. s:lst>.:::ndr::d 
· J t · f o 2 --O/ I ln a n aqueous s o.u lon o - ~~ w v agar d - . . . . a.n C:·.a;m_nJ. s t e.r.f:!<.: 
100 g .bocly ·,:o;;: i~-; !'1 ·t •. · U .r. al d os ing was sel2cted , .... ~i L 
drua suspensic~s were p r epare d daily ~ 
The adr.l i nistra U.on of' a J.l test drugs v-;a::; initi2.-l:e d 
1 day pr ecedi.ng a.C.juv.s.nt inj e c t ion a~c! ccr.tinue0. ·.:aily 
received ·:.;nJ.y t:1 •.::! recn.:i.s i te vol ume of tb.e age,::- vehicle . 
To dete~mine the progress of t~e infla~m~tory response 
in the polyarthri tic rats 1 several metameters \..:ere 
collected utili zing the following methods . 
Plethys~graphic DeterminatiC?.,:r.l__£f Hind Pa1t1 V~~~~· -·­
Both injected and contralateral paw volumes were mea~ured 
plethysmographically by displacement of mercury usi.ng a 
procedure similar to that described by Winder et ~~· 
~6 ) . Hi nd paw volume measured to an indi a ink line 
across the l ateral malleol us was determined by the dis -
p l acemen t of mercury i n a ver tical l y uniform plexiglas 
vessel (diameter = 2 . 5 em , height = 6 . 0 em) . The resulting 
, 
c hange in pressure \vas determined wl th a pressure trans ducer-.:.::. 
1 Statham pressure transducer P23BB . Statham Labora tories 
Inc ., Hato Rey , Puerto Rico . 
, 
g a.' .J<:<e c o~.;r. ~ . .:..'.c.:.:: .• 
· ~ 
;;. J:- ~.:;~_::1 ~· .. :::!'·- ca}.:,a.c :; .. t.')~·.' :1 ,~.:::-,:.• .. · :c·~~·f.:-..:~. ~ : !·).:..:.; 
s i gl::.~t ls usually encountered at the sensitivi ·i.:y 1.ej"'"::.s 
of n:east.:.re;q,=nts ( Fi.gc.re ., ) 
. : • , 4t 
percentage i nhi b i t i o:n oi ir..srt::a::: '2d f~)O t . ·~roJ.tF:.:: 4 ·?h"J 
f ollowing forr.tu ln. v1as e<nplcye ... i : 
Percentage inhibi t ion = 100 1-Ka~x) / (b-yJ 
V.lhere y -= mean foot v o lume of control rats immed5.clt.e J.y 
prior to adjuva n t injection, b = mean foot volume of 
control rats on a particular day , X = mean foot VOlume: 
of drug- treated r ats immediately pri or to adjuvant 
~njection, and a = mea n foot volume of drug- treated ~cts 
on a particular day . Paw volumes were deter min::;d ~=:very 
thir d day commencing on day " 0" through day " 30 . ! I 
Arthritic Index.-- A subjective scoring sys t em f~r 
assess i ng the progr e s sive development of the incuc~d 
1 
,. ... ,. ,_., ,-y;:·~,..., + -·.,-in .-. ·~ae C"O ll~ler ,...,b er·':rrna,..., r~ - .t.J:' I 'T\'leY"'tS ..,..n_ 
--:t ?~ :;A.J ~ :_ ~ .. ~..J.. ~~(.1, .J -'. -~ • : . .. _ - ~ ... . \ .... • J.!.:: '..... ....,_._ . ~ - ' .l. ......... . 
""' •' 0 () ~. 1 ,,,..,r Roar< Sch' 1 • ..... - ·J- r•.r Tll· ..... ), s 2 ~ .;,.• •J i\.-\, ~ t',; 'o ·4' I - • ..L.....L.'.. ... ).. -d. J • .. ' --- ....1...4.1.\. _.,, _. 
Hodifl.cc.tivn of the Cyr:ograph was ir.s 7..: ituted by 1v!.r' .. Frar.k 
A .. .!'-TcKe11na o .f 8eck:m.3.:-. Ins ::rur:,•::::-. ':s 1 Iz:c . 
APR 
Figure 2 . -- Recording s ystem employed in foot volume 
determinations 
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a.t:i:hri tic syndrome was employed ( 28 ) ., 'l'he se\;-eri i:.y of 
the arthritic lesions in each of ·the four legs 1t.JciS 
ass~gned a value of 0 to 4 according to the extent and 
degree of i nvolvement . Criteria for grading were the 
severity and extent of edema and erythema of the 
peri articular t is s ue, and the enlargement1 distortion 
and ankyl osis of the joints . Therefore, the arthritic 
score for any one animal could range from 0 to a maximum 
score of 1 6 . The arthri tic index i s the mean of 
individual scores for a group . Various lesions 
asso ciated with adjuvant-induced arthritis are illustra.tc=cl 
in Figures 3 . and 4 . • Scoring was visually assessed every 
third day following adjuvant injection (day " 3 " to " 30 '.' ) . 
The P.ercent inhibition was determined by comparing th.:: 
index of the drug- treated group to that o f a positive 
vehicle control group . 
Impairment of B,ody Growt h .-- To assess the general 
state of health of animals during the course of the poly-
arthritic disease , mean body weights were determir.:ed fer 
both control a nd drug-treated groups initially and at ~ 
day intervals during the 30 day observation period . T.n 
addit~on7 the adrenal glands , spleen and thymus were 
removed and weighed from control rats and from drug-
treated rats sacrificed 15 , 2 1 and 30 days after the 
injection of adjuvant . 
Effect _..£f_<;_rycgeni~ on ?rev iou s l y Established 
Arthritis .-- Arthritis was induced in a surplus number of 
!6 
.I 
Figure 3 .-- Secondary Les ions in Polyarthritic Rats (Left - Positive 
Control, Righ~ - Negative Control.) 
I 
A. E~n:ly signs of ear lesions, Day "15" ' , 
B • . Swelling ot front pmvs, nose and head ::~.rea, Day " 2 1" 
C. Nodular S\Yt!lling of the tail an<! h.ind pa\vS, Day "30" 
F:i.gure 4.-- Secondary l esions in polyarthriti.c rats (Left - pos itive 
control, Right - negative control) 
' 0 J ~ .: 
I 
positive c e ntr a l r ctts by methods descri~ ed ab ~v2 ~ r·. --. ' -' :.. .!. 
ar thr itic s yndr ome was fully d eve loped ), r ats Wlth ffie a n 
paw volumes exceeding 2~50 ml were selected a nd ~~ ~ced 
in to +:·1\'0 experimental groups of 4 anima ls each., O!l(C: 
group was treated daily with cryogenine acetate (10 0 
ng/K9 in aqueou s 0.25 % agar, ora lly ) for 7 days , whil e 
the other group received an equivalent volume o f the 
agar vehicle only (5 ml / Kg ). Paw volumes and arthritic 
index determinations were assessed daily. 
~erum Turbidity in Ad juvant-Injected Rats.-- The 
polyarthritic disease was established in expe rimental 
groups of rats as described above. Serum turbi d i ty 
levels were measured in 8 negative and positive control 
animals (4 agar-treated and 4 nontreated adjuvant-
injected animals). In addition, serum turbidity was 
determined in rats treated with cryogenine and the o~:.::i~ . e,;::-
selected antiinflammatory agents orally for 21 days . 
Serum turbidity determinations were made 20 days fo l lmv:i.n(j 
adjuvan t administration using a procedure simi l ar to that 
described by Piliero and Colombo (29). Rats, lightly 
anes t he tize d with ether, were exsanguinated 
puncture. To 0.1 ml of nonhemolyzed serum, 
l/15 1vr Sorensen phosphate buffer.! in sv.line 
2 .. 9 rr, l o f 
at pE 
1 Composition of buffer: 2 ml 1/15 ~alar monopotassiuro 
phosphate + 98 ml 1/lS mo la r disod i um phosphate. 
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were add e d ~nd g0ntly agitated. Ths mixt~re was a llowed 
to stabili3 e at room temperature for 15 minutes~ The 
m~.x ture \vas t h e n he a ted in a constan t temper· a ~.-.ure >tiC.'. ter 
ba th at 69° C for 30 minutes at which time the samples 
were immed iately cooled in an ice bath and r edd ln a 
1 ~- pec trophotometer- at a wavelength of 645 mp. Char: ..g(::s 
in turbidity were based on the degree of absorbancyw 
~matological Studies in Ad~vant-IJ2i~S1=.~~:h~·-···· 
During the course of the adjuvant-induced a rthritic 
syndrome, hematologic studies were conducted in animals 
from both positive and negative control groups (adjuvant-
injected agar-treated and noninjected agar-treated groups ~ 
respectively) and in the arthritic groups treated with 
cryogenine and the other selected antiinflammatory d~ugs n 
Differential white blood cell counts from smears stained 
with tetrachrome£' and total white blood cell counts 
determined with a Coulter counterl were recorded or: da.ys 
"6" 7 t1J.S", "21 11 and "30" from blood obtained from .-cats 
anesthe t ized lightly with ether and exsanguinated by 
cardiac puncture. Erythrocyte sedimentation rates were 
also determined in all groups. A 0.4 ml volume of a 1 ::::ot ...;. • .._! /0 
EDTA solution, employed as an anticoagulant, was a dded 
to each 2 ml sample of cardiac blood. Sedimentation 
rates were measured as mm fall per 2 hours. 
1 
20 
2 Bausch ,'S< Lomb "Spectronic 20". Tetrachrome stain #63 7. Alliad Chemical Corp. 
New York. 
:!'few York, 
3 Coulter Counter, I'1odel F. Coulter Electronics, Inc .. 
Hialeah, Florida. 
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Heal thy adul-t: male a l b ino gm.n ea p .J.c;s of b~-.::-: Hc::u· L:i.ey 
.stra5.n He ic:;hing 300-400 g were e mployed t·hr::J t:g ho u:: t~·J cc.s c 
stua1es . On arriva l, the animals were hous eJ in pa1rs 
in med ium-sized wire floor cagese Purina Guinea ? ig 
''h-- 1 d t C 1 t d · th o 25 I - ·b · '-- U\oJ-- an wa er supp emen e Wl - • mg mJ. a. sc:or 'J. c 
acid) vJere supplied ad libitum. Ambient room temperature 
was maintained at 73-76° F. Sixteen hours prior to the 
standardized ultraviolet exposure, the ventro-lateral 
surface of a flank of each animal was depilatated with 
a commercially available calcium thioglycolate prepara-
t . 2 lOn-. Following depilatation, animals were randomly 
assigned into experimental groups and sequentially placed 
into individual cages to allow for a constant leng~1 0£ 
time bo elapse between depilatation and ultraviolet 
this time. All drugs were administered orally using 
standard feeding needles attached to 2.5 ml glass s y ringes . 
Drugs were either administered as solutions or finely 
3 triturated suspensions in 0.25 % aqueous agar-~ The 
constant 'lolume of injection was 0. 5 ml per: J.OO g body 
weight. Experimental control animals r:eceived t he agar 
vehicle only. To facilitate dosing, the guinea pigs were 
l Crude protein not less than 22.0%, crude fat not less 
than 4.0%7 crude fiber not more than 18.0%7 added 
ml"no-alc n-~ l e ss ~~l-r· 3 ~ ~ 2 ---R_ 1-.J _.u..... ·-!cil ~_, ,c- . 3 Neet"; Whi te l ~all Labo.L·atories, Inc .. , New York, N .. Y. 10017. 
Difco Eacto-agar, Difco Laboratories, Detroit, Michigan-
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a.nd body.. Ei .c: h dose level of a test dru.g VJ<JS aclrni!.!.i::; l.::er·ecl 
to an experimental group consisting o f 5 animals~ Eac h 
dose was administered in two equal parts separa ted by a 
one ho~1r inte rval. Immediately following the second 
dose , the depilatated surface of each animal was exposed 
to the standardized ultraviolet irradi a tion for a period 
of 70 seconds., 
The apparatus employed for inducing the erythemic 
response is illustrated in Figure 5 • A 3/8 inch thick, 
20 inch square of opaque plexiglas was positioned 
directly above an opaque shutter. The ultraviolet source, 
12.5 em below, consisted of a Hanovia high pressure qua~tz 
mercury vapor lamp ( 45 0 Watt)! mounted in an Alzak 
1 
aluminum reflector hood assembly-. The base of the 
reflector housing was secured to an adjustable support 
2 platform- to facilitate the positioning of the lamp. T:1e 
radiation directed upward from the reflector was passed 
through a 6~ inch square molded Vycor heat absorbing 
1 
filter..:.:. positioned above the ultraviolet light source 
and directly below the shutter. A milled-~out area in the 
plexiglas (1 x 3 inch) accommodated an opaque plastic 
plate into which three equally-spaced 6~ mm diameter holes 
l Supplie~ by Hanovia Lamp Divisicn, - 100 Chesnut Street, 
2 Newark, New Jers ey 07105. Precision Sci en t.if.ic Compan}', Chicago, Illinois* "Big· 
Jack" support plu.tform. 
--------------------------------------------4~ -· -~------------------------------------------
Figure 5.-- Apparatus employed in ultraviolet induced-
erythema experiments 
0 ci :l. :3 t . (l rc r.::. 2. 
pla::d:i c p lcd .. e ., J'Le duratio n of u l t r 2'T:Lc 1et r::xpo ::. L.: . :c ~::: 'tic:.5 
a.utomc.C.ic: e:cl :l. y c o n trolled b y the ac t iva tion o f ;:::_n el e c i::r ic 
:Lnte.rvu. l t i rn erl:. which ene r g i zed a small s o l e n o i d a t tach ed 
to the shutter. 'rhe lamp was allowed a "warm up" pe .:~ i::.,:..i 
o .f 30 minutes prior to use. 
The effectiveness of the drugs in delaying or sup-
pressing the ultraviolet- induced erythema was evaluated 
using a modification of the methods described by Brittaic 
and Spencer (30) and Winder et al. (31). The average 
intensity of the resulting erythematous circles as well 
as the appearance of the non-exposed depilatated ski:J. 
va.ries markedly among similarly treated animals"' Ra t:hs:c 
than attempting to quantitate the degree of "rednessn ·'):C 
skin, a rating sys tern similar to that described b y 'i'Ji ndc;;:· 
.~_t.;, .5:'-l..- ~t~a s e mployed based on the 11 definiteness" or nil: -
def.:Lni Lene ss 11 of developing erythema. An ex p o ;::.ed spot 
demons -tre.i::i. ng no apparent erythema = 0; <:~. spot wi 1ch :::li :]ht 
erythema, a nd poorly defined borders a. Spot S DO \'./J.r.q 
moder.::.t i:e e z·y thema and defined borders = 2; a f ull circle 
of ma.rked ery thema = 3. The average '' definiteness" of 
the ·thr~2 :::- (=: sul t .ing erythe matous c.ir<::L ~:."! s vJas es ti rna ted at 
l hour in ter'rals for a period of' 3 hours" The average 




scc~e was determi ned ~or co~t=o l ani~a l s a n d fe r t he 
e~per imental animals at each dose l eve l c£ the t est 
compounds. The responses of each experimen tal group o f 
5 animals we re summed ( group inflammatory score) a nd 
p lo t ted against time. The area under the tur.e-responses 
cruve represents the level of inflammation over the 3 
hOi..lr test period. The area beneath the curve, plotted 
f or each dose level of a test drug, was determined a nd 
expressed as a percentage of the response for untreated 
control animals. The protective efficacy of drugs 
against ultraviolet-induced erythema was determined from 
log-dose response curves based on tests at at least three 
equally-spaced, log-dose levels per compound. The percent 
inhibition of the control group response produced by a 
test compound was plotted against the corresponding dose 
----------~.---~------~.-~~~--~----~~---------~------~l---.wc~~~~------------level on probability-logarlthmic graph paper-. <ose 
necessary to reduce the value of the control res ponse by 
half (Eo50 ) was graphically determined from the resultant 
linear expression. 
3. Acute Cardi ovascular I nteractions 
Healthy adult male rats o f t he Sprague- Dawl ey strain 
? 
were anes the t-:ized with Dial-Urethane-=- ( 0 .. 1 ml per 10 0 g 
body weight) administered intraperitoneally. Following 
tracheal intubation, the l e±7 t common caro tid artery \vas 
J. 2 Keuffell & Esser Comp any . # 359-24. 
Dial with Ur ethane So l ution , Ciba Pharmaceutical Co ~, 
Sumrni t, New ,Jersey,. 
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trunk. A po lye t hy l e n e canr:ul a ( P . E , 5 C) •.r.~c-, s i n :>~'!r tel i n t o 
the artery and blood pres sure wa s monitor ed by ~e a ns of 
a Statham pressure transducer1 employed in cz.;njunc ·c::.cn 
2 
wi. th a str ain gauge coupler- and recorded on a Be:c\:rnC!n 
Dyncgraph . A short catheter (P.E. 10) was inser t ed i~to 
the left f emoral vein for the intravenous inj ection of 
all drugs. The constant volume of injection was 0.1 ml 
followed b y a 0.1 ml wash of 0.9% sodium chloride solution 
to insure accuracy of dosage. All drugs were dissolved 
in 0.9% saline. The following drugs were used as 
"challenge '' agents: acetylcholine chloride, epinephr:Lne 
hydrochloride, bradykinin, serotonin creatinine s ulfate , 
and histamine dihydrochloride. After determination of 
standardiz ed responses produced by intravenous injec ~ions 
acetate wa s administered in cumulative doses at 10 mirmte 
intervals followed by the test challenges 2 minutes l a ter. 
Mean arter ial blood pressure was determined prior to and 
immediate l y following each drug administration. 
The e ffects of cryogenine on the test challenge 
responses were estimated b y comparisons with the standar-
dized res ponses evoked by the test challenges before 
1 Statham pressure transducer P23 AC. Statham Laboratories 
2 Inc., Ha te Re y , Puerto Rico. Type 98 7 2 strain g age coupler, Beckman Instruments Inc., 
3900 River Road, Schiller Park 7 Illinoi s . 
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cryog2nin e admi ni strabj~n. 
To teEt antagonism of bronchocons t..d . c tion induced 
by bradyk inin 1 his tarnine and 5 -hydroxytrypta.rn:Ln.e , qu i ne a. 
pigs of either sex ( 5 00-1200 g) were anesthetized wi di 
urethane (1.5-2.0 g / Kg i.p.). The resistance of the 
guinea pig lungs to inflation, in vivo,. wa.s determined 
by a modification of methods originally described by 
Konzett and Rossler (32 ) . The trachea was cannulated 
. l 
and the lungs inflated with a small animal respJ.rator.:;. 
operating at a rate of 66 strokes per minute in a 
partially closed system at a constant stroke volume 
(3- 7 cc). ~Che stroke volume was adjusted at the beglnn. J.. ng 
of each experiment to produce a minimal ove r f low volume 
of air through a sidearm in the tracheal cannula. Broncho-
constriction was assessed from the increase in the air 
overflow which was determined by means of a small volu-
metric transd~cer~ employed in conjunction with a polygraph 
3 
recorder-. 
All bronchoconstrictor drugs were dissolved in a 
solution of 0.9 % sodium chloride and were injected in a 
constant dose volume of 0.1 ml through a shor t polyethylene 
1 Miniature Ideal Pump Assembly, Model # 5119/04 manufac-
2 tured by C. F .. Palmer Ltd. Carlisl e Road , Lo ndon, England. 
Statham pressure t ransducer # PT-5. Statham Laboratories 
Inc., Hato Rey , Puerto Rico. 
-3 Grass Model 7 po lygraph, Grass Instrument Co. Quincy 
Mass. 02169 . 
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cathe t e r (P.E. 5 0) i n ser ted into the l ef t ex terna l jugular 
vein . Drug inj e ctions were i mmediately followed by a 
0 . 1 ml 0 . 9% saline wash . The fol l owing drugs were used: 
histamine dihydrochlorid e , 5-hydroxytryptamine ( s erotonin 
· • • J f t s H'r ) th t · b · k · · 1 d crea-clnlne su. ·a e , - , syn. e 1c racy, 1.n1.n- an 
c r yogenine acetate • . All doses are expressed as the base 
form of the drug . 
The effect of cryogenine on bradykinin-, histamine-, 
or serotoni n- ·d.nduced bronchoconstri ction was estimated 
from comparisons between the response evoked by these 
agents when admini stered 5 minutes prior to and at 5 or 
10 minu t e intervals fo llowing intr avenous admi nistration 
of c r yogeni ne . 
5~ Gangl~onic Interactions 
A s eri es of experiments were performed on the superior 
cervical ganglia of young adult (250 g) Wistar rats 
(Charl es River) . The surgical and r ecording procedures 
e~plcyed in this study were s i mi l ar to those descr ibed by 
!-Iancvck et al . (33 , 34) . Rats of either sex were anesthe-
t ized ;.,ri th a mixture-S of a l lobarbi tal ( 100 mg/ Kg) : 
uretha~e (400 mg/ Kg) and monoethylurea (400 mg/ Kg) 
administered intaperitoneally . Following intubation of 
the trac hea , t.he left Superior c ervic a l ganglion was 
1 Syn thetic Bradykinin (BRS 640 ) Sandoz Pharmaceuticals , 
2 Hanover , New Jersey. Dial wi t h Urethane Soluti on . Ci ba Ph armaceutical Co . 
S~mmit, New Jersey . 
29 
expos ed by retraction o f the upper r>urtion.s o f the -tl.~ a.cht~;;-.. 
and esophagus and L'eflect:i.on of the lo~l_ll~ .S~.i ~~~ muscl e . 
The postganglionic nerve (external c arotid) was identified, 
ligated and sec1cioned at its point of contact vii-t:h the 
external ca.roticl artery. The cervical sympat hetic trunk 
was dissected free from the vagus nerve and common carotid 
artery and sectioned at a point approximately 0.5 em above 
the clavicle . All major branches of the common carotid 
artery, except those supplying the ganglion were tied. The 
ex~ernal carotid artery was ligated at the l evel of the 
occipital artery. Similarly, the internal carotid artery 
was tied approximately 5 mm cephalad to the superior 
cervical ganglion. A deep cervical well was formed by 
tyir19 skin 'flaps to the supporting metal framework. The 
exposed area was covered with mineral oil . · Supramaxima l 
stimuli of 0.2 msec duration were applied to the~rvical 
syrnpa the tic trunk by means of a square wave genera tor}..:., 
the output of which was passed through a stimulus iso l ation 
•t1 ' b' 1 1 t ' 1 t d unl - co lpo ar p a lnum e ec ro es. Unless indicated 
otherv1ise, the sympathetic trunk v1as stimulated at a rate 
of 0.3 cps. Ganglionic potentials evok8d by drugs or 
preganglionic stimulation were recorded from the surface 
of the ganglion by means of silver-silver chloride bipolar 
electrodes. One electrode was placed in direct contact 
1 Stimulus isolation unit Model SIU 4 7 Square wave 
stimulator Mode l S 4. Grass Instrument Co . Quincy, 
r1ass. 
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with the surface of t:he gang1ion , t.he othe:r: f:h.r.·o1Jgh a. 
saline saturated silk ligature o n the crushed end of the 
postganglionic nerve . The evoked potentia ls were 
~ 
ampl ifi ed by a r es i stance- coupled preamplifie~~ ~nd 
visualized on a::1 oscilloscope£. Drug-evoked as:~{~lc!"Lronous 
postganglionic activity was recorded by mean s vf :!.:'i pol~.r 
platinum electrodes placed in a similar ma nner ·to that 
described above and ampl ified through a capacita nce-
c oupl ed circuit. All drugs were administered intraa rterial-
l y through a 27 gau ge needle inserted i nto the common 
c arotid artery and secured to the supporting framework ~ 
The c onstan t vo l ume of i njection was 0 . 05 ml. All d r ug s 
were dissol ved in ~ sol ution of 0 . 9% sodium chl oride . 
Cl otti ng i n the needle was prevented by t he prio:r adm.i.n- . 
i nstrati on of he~arin (400 U/ Kg , intraarteri a l l y ). The 
f o llowing dru g s were used : acetyl cholin e chloride , 
methacholine chloride , oxotremorine pic r olonate , a tropine 
sulfate , potc:rssium chl oride , hexamethonium chlor i de , 
epi nephrine b itartrate , levarterenol b i tartrate , cl 7 ];.-
isoproterenol hydrochloride , serotonin creatinine sulfate 
( 5 - !-IT) , 1 , 1- d i methyl-4- phenylpiperazinium iodide ( DMPP) ., 
tetramethylan~onium chloride (TMA ), physostigmine sali cy-
l a t e , 4- (E:_-chl orophenylcarbamoyloxy )- 2- bu·tynyl tri methyl -
ammonium chloride (McN- A- 343) and cryogenin e acetate . 
1 
- Gr ass Model P 6 preampl ifi er . Grass I nstr ument Co . 
2. Qui ncy , Mass . 
- · Tektroni x , Inc. Mode l 502A . 
\.V.i. t.h the exception of cryogen:i.ne, D.ll doses reff.:> r t.o the 
salt form of the drug. 
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"RESULTS 
1. Ad~vant-Ind~~~ Arthritis 
Pl~t_l].Y.smograp_h,ic Determinati on of Hin9__~Y.£~lll:~~.b --
The s ing l e injection of heat- kil l ed Myco~~riu~ 
.£.s.ti~-'b.S'::.I! into the p l antar surface of the rig ht h :i_ nd pa w 
produced. a sys t emic arthritic syndrome in a ll. c o n b :-o l 
group aninals . Marked inf l ammatory swelling was noted 
in the injEcted pa\v (primary l esion) vdthin a period of 2 
hours fo llowing adjuvant injection and this swel li~g 
continued to increase for 8 or 9 days . After a p lateau 
stage , a further increa se in paw volume occurred a nd 
per sis ted for the remaind er o .f the 30 day observation 
period . Sec ondary les i ons , associated with t he acute 
phase of the disease and evidenced as swel l ing in the 
contralateral (non- injected) paw , became apparent 13 to 
17 days after adjuvant injection and progressive l y 
increased in severity for the nex t 12 to 13 d ays . The 
drug treatments emp l oyed from days " 0 " through " 20 " are 
listed in Tab le I · The therapeutic efficacy of these 
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Mefenamic Acid 25 
I ndomethacin 1.0 
Parame thasone 0 . 5 
Hyd rocor t isor.e 10 
6-mercaptopurine 2 . 0 
l. All drugs adminj.stered for 21 days ·oeginnin g one day 
prior t o adjuvant administ r ation . 
JJ 
a.9ents \vas assessed at three day intervals during the 
c ourse of the adj u.va.n i: dlsea.se ., Foot vol,Jme determi n e.- · 
tions indicated that all of the test agents inhibited 
~1e inflammator y s welling to v arying d egrees ; however , 
none prevented the j_nf'larnmation seen immedi a t ely fo llowi::1g 
the adjuvan t inj ec tion. Th e therapeutic effects produc ed 
by the test compounds on the primary and s econd.:1.ry lesions 
(injected. and contralateral foot volumes , res pectively ) 
are graphically represented in Figure ~through Figure 12. 
Inhibition of edema in the injected foot was achieved with 
ir1domethacin 7 phenylbutazone , hydrocortisone and cryogenine 
at the dose l~vels employed. Secondary l esions in contra-
lateral (non-injected ) paws were significantly suppressed 
by all agents tested during the perio d of therapeutic 
treatment. After cessation of treatment these beneficial 
effects persisted especially in animals treated with 
paramethasone c:.nd to a l esser extent vJi th 6- :nercaptcpurine, 
phenylbutazone and cryogenine . Contralateral feet o f 
paramethasone-treated rats appeared essentially normal and 
equivalent to non-inj e cted c ontrol animals at the termina-
tion of the 30 day observation period. The therapeutic 
effects elicited by dai ly dosage of indomethacin, 
hydrocortisone and mefenamic c:.cid however, were not 
sustained after cessation of dosage. This l ack of protec-
tion was r eflected by a significant increas e in paw volume 
soon after drug treatment ended. A summary of test drug 
effects on the course of adjuvant-induced arthritis is 

fcx.)t vo:urne (rnl) 












f;$ ~ :!.11,j c•.: i;.ed fo;)!: vo.l ume of pon i ti v e cor/ c.r ol c::. o :'.nt~.1ls 
Q :::: ir~j e~ted . .foo·c vo:umle of phenylbutal.o;~c-·t:c e~'. Lr~d. nnirr.al~; 
Ll ::: coutral :::.ter.a..l. f oot volume of phenylbl..rt.f'.ZOr. te~t:re .9.ted :.-.ni:;n.g,ls 













6= injected foot volume of positive control animals 
0 = injected foot volume of p~ramcthasone-treatcd animals 
m= contralateral foot volume of positive control animals 
0 = contra.laterar foot volu.1ne of paramethasone-treuted animals 
Figure 8.-- Adjuvar:t-induced o.rt7 hr±t.:.s ::.n rats treated '~>Tith 
parametha·sone ( 0. 5 mg. /Kg. ) 
.· 
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1·P '-----6---~2·--___;18_L·--24---30 . 
time (days) 
$ - in.,}~cted foot \'o lume of positive c~>~t:col az1 i 1naJ.s 
0 - i nj·ected f oot voluw.e of 6- P.'ler""!a ptCJ'1Lri. ne- ~r.e2:~e(t anim:::.J.s 
~ ·~ contr alateral foot vol1.nne of posit:. ':o centre l ani!:ml~ 
·Fi e-ure: 9 ,-- Ari.juvant- induced arthritis in rats tree.t-=d '.tith 
6- ner captopur.ir.e ( 2. 0 mg . /Kg . ) 























ti) =:= injected foot volume of positive c ontrol ani:aals 
0 = injected foot volumE'! of hydrocor·cisone-tr.eated animals 
I'J = contralateral foot vol;.une of positive control animals 
0 = contralateral foot volume of hydrocortisone-treated ani mals 
Figure 10·-- Adjuvant-ind.llCed arthritis in rats treated with 
hydrocortisone (10 mg ./Kg .) 






0= injected f oot volume of positive central animals 
0= injected foot volume of indomethacin-treated. animals 
II= contralater al foot volume of positive cont:col animals 
0= contralateral foot volume of indou;ethacin-treated animals 
Figurell.-- Adjuvant-induced arthriti s in rats treated with 
indomethac in (1.0 mc./Kg.) 





· / -;,:.~ 
0 "' inj C't'ted. foot. volume of positive cont1·ol animals 
o~~ injected foot velum~ of mefe!1rutt:i.C G.Cid - treated animu.ls 
'-1= contrd.la.ter l}.l fo,yt. vo.l!m.c of positive cont. t·ol ani mal s 
0.., contral at eral foot volume of mefenamic acid-tr~a~ed ani mals 
Fig'lre 12.-- A.<ijuv a nt-induced. urthr:i.t.:.s in rats -.reat~d '·"i t.h 
mefenamic acid (25mg,/~~ .) 
fG'(1t volurne (rnl) 







pres0nted i n Tables II, III, and Tables IV , v. 
;:-s:SbE..~~t~:--~~~~ .. - ·· The local inflamma tor~·- response 
elicited by the subplantar injec t ion of mycobacterial 
adjuvant occurred almost immediately after administration 
J.n all control group ani:Tta 1.:;.. The initial edem.:d:ous 
rec;c~ion pla teaued usual ly within 3 or 4 days ; however 7 
a. moderate level of S\-velling continued to persists until 
Day "13" to Day "15", at which time , the beginning 
manifestation of secondary l esions became e vident . These 
were noted as increased vascularity of the ears , n odular 
l esion.s of the nose and tail , and swelling of front and 
contralateral (no~injected) hind paws. D Ear lesions , 
which ~·Tere first observed a s areas of apparent capillary 
dilation, dev e loped into :i_n:f lammed nodules , Simil ar l y 1 
early l es i ons of the tail increased in severity and 
caused a marked increase in ta.ll fh ickness . Secondary 
lesions of t.h e hir.d feet v;eJ::-E: observP.d initially as a 
diff use erythematous s·,..;el l ing of the dorsum of the tars3.1 
r egion and ankle: joint s with attendant inflammed fusiform 
swelling o f one or more digits of the paw. The d issemi-
nated arthritis deve loped at a relatively slow rate , but 
progressively increased in severity over the 30 day 
observation period . 
49 
Figure 13 . to Figure 19 . indicate the therapeutic effi-
cacy of cryogenine and the selected antiinflammatory agents 
on the course and develop~ent of adjuvant arthritis as 
I il I 
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Pilenylbu ta zon~ 
Hefenamic Acid 
In d ome t hac ir. 
Parame t hasone 
Hyd rocortisone 
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Table V.-- Effec ts of Drug Treatments on Non-Injected-Paw Swelling in Adj uvant- Induced Arthritis 
--------------- - P-erc~~~-i~hfbi t~oil -of - I~-~re~~-ed -Fo~-t--Vclu:ne 
r Trea tment Group I I I I I Day 15 Day 18 Day 21 Day 24 Day 27 Day 30 I _t _ _ __ I ~gative Control -- -- l -- I -- -- --




-- -- I --
Cryogenine ! 93.5 I 87 . 5 I 86 .4 I 81.5 48 . 6 I 55 . 6 I 
Phenylbutazone I 74 .2 I 81.3 I 83 .1 i 80.0 65.7 I 67 . 9 I . I i I I 
I I 
Hefenamic Acid I 11 2 . 9 I 93.8 ,. 89 . 8 I 75.!1 51.4 i 37 . 0 
I I 
Indomethacin I 71.0 I 62.5 I 66 .1 I 75.4 54 . 3 I 45 . 7 
I I Paramet hasone I 125.8 I 102.0 I 105. 1 I 100 . 0 I 98.6 I 95 . 1 
I I l Hydrocortisone I 90 . 3 I 87.5 I 86 .4 I 67 . 7 61) . 0 i 59 .3 



















Q--0 = arthritic i:-,dex for po:j it i.ve c ont:n;l anim::~.lG 
Figure 13.-- 8c:r.parative al·-:1.ritic inde:z ~or !'::tts treated with 
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o~--6 12 1s' 24-·--Jo-
.. Time (Days) 
55 
0-·-{)= a r thritic index f o r pos i tiv ·~ contr o.i animals 
9---e•= arthri.t ic .Lndex for phenyl butg,zur.e-·treate:i aui:nals 
Jt':i.gure 14.-- Co~pa.rati 'l e arth~4iti c i ~dex for rnts tre nted "H'i th 
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Tirr1e (Days) 
57 
r'igt:.::e 15 . -·~ Ccmpa:rati ve ar ·t.tu:i tic ir.riex f or r r.Lt s treatt.=.:i ''"itt 
6-l."l.ercaptc;pur .l.ne ( 2 . 0 mg./Kg. ) 
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o--o= erthriti~ irrdex for po:;itive control a nimals 
<®---®= arthritic index fox· pa.ra::ne·~h~sone-treated cmimals 
Fig-J.:re 16.-- Con:parative arthritic index fer ra~s treated. vit h 
paramethascne (C.5 mg./Kg.) 

























o--o= arthritic index. for pod ti ve control animals 
~= o.;.·thriti~ index for mt.:fc~narnic acid-tre2.t~d ani;na:s 
F'igure 17 • -- Co:upa.r~ti ve ar"ti:ri t ic index for rat s treated with 

























Q--0= P..rthritic ir.G.ex for pcsit:i.ve ~ontrol n.ni;-:,Ja1z 
Q)--N-$ = arthritic index i'or hydr-.:.•·:ort isonE:~·t;:~eated an..ir;i8.1c 
Figure 18 .--Comparatiire arth~itic i11d:2x for l~ats treat:ed vith 




















o--o= ar.thr:i.tic index for posit ::.·r ·~ r.~on trol animals 
(;---0= arthritic in:le:.< fo:=· ir:.rl.nl·:et:lacin-tren:t~d animals 
Figure 19.-- Comparative o.rt:n·itit:: index for :rats t!' ~ated v:itn 































determin<:~d b y i.:h~ v:i. s u u. l sco.r i ng s y s tem, Trea tmen t o f 
all animals wa s initiate d one day prio r to a d j uv ant 
injection a nd was continued t h r oug h d a y '' 20 " ., Unle s s 
indicated otherwi se , e a c h po int r epr ese n t s the mean 
arthritic index scorE: f o r a g r oup o i 10 rats e n a 
particular day .. 
All anima ls in t he positive cont ro l g r oup ( r ece iving 
agar vehicle only) d eve l ope d either moderate or seve re 
polyart.hritic lesion s which were f irst observed on d ay 
68 
"12" to day 11 15" and prog.r:essi vely incr:eased in s e ve.ri t y 
for the duratio n o f t he 30 day obs e rvat ion p e r i od . The 
cytotoxic· a gent, 6 - rner cap t opurine , and ( t o a l e sse r ex .ten t ) 
parame ·thason e and h y d r o c or t isone wex:e the only ?.gent s 
tested which pro d u ced s i gnif icant protecti on a g a inst the 
initial inflammat ory r esponse ( d ay "0" through " 6 ") .. 
However, rats tre ate d with cyoge n i ne ar~d the other s elec ted 
tflerape u t ic a g e nts, (with t he excep tio n of i ndo methacin) 
were a fford e d signif icant protection du r ing t he acute 
phase of the arthritic dis e a se .. The ar t hri t ic index and 
therapeutic eff icacy for all treat ments are sum~arized in 
Tab le VI. Following t e rmination o f d r ug trea tment 
(day '"20" ) the severity of the c.r thritic syndrome 
increased in all groups; however , signif ica n t protec t ion 
was still evident at the end of t he 30 day s t udy in rats 
treated with cryogenine , hydrocor t isone , 6- mercaptopurine 
and phenylbutazone. 'rhe various manifes tc.tio ns of the 
disseminated arthritic disease did no t appe ar in the 
r __ I 
I 
Table VI.-- Art:hri.tic Index and Therapeutic Eff_icacy __ of_ Drug Treatments i n Adjuvant- 1.nduced Arthri t is 
Ar t hritic Index Percent Inhibition~ 
Treatment Group Day 12 Day 21 Day 30 Day 12 Day 21 Day 30 
Positive Control 3. 3 6.5 10.2 -- -- --
·I 
Cryogenine 2. (]12. 3.~ 6.~ 39.4 50 . 8 39 . 2 I 
I 
Phenylbuta zone 2 . 9 3. 6.12. 6 . 7.12. 12. l 44 . 6 34 . 3 
d 
Hefenamic Acid 2.4 4 .o!2. 8 . 6 II 27 . 3 38 . 5 15 . 7 
I I Indomethacin 3.1 4.7 7. 3 6 .1 27.7 I 28 . 4 i I I I 
2.4.12. 3.~ I i Paramethasone 2 .4 27 . 3 63.1 I 64 . 7 I I I 
II 
I I 
Hydrocortisone b 3.# 3 . 9.2. 48 . 5 49.2 I 6 1. 8 I 1.. 7- I 
II l 6- mercaptopurine 2.# 2 . &t I 4 . ~ 30 . 3 60.0 j 50 . 9 I ~ 
a 
- Determined by comparison of drug-treated gr oups \-lith pos i tive control group values 
.!?..Significant ly different f r om Positive /control group valnt:s (P = 0 . 05) 
o-. 
'-0 
pa.re1methasoEe treated group for 8 days after dn1g t.recJt: ..... 
ment was terminated ~ 
recorded at the start of drug t ree>.tment (day " 0") and. at 
3 day inte rva l s to the conclusio n of t he observatio n 
peri o d (day 11 3 0 " ) . 'rhere were marked differences in body 
wei gh t patterns between nonarthritic and arthritic control 
group animals (Tab l e VII. ) In rats injected with the 
Mycobacte.t;.i11.~ ad juvant, the avera9e gain in body ~,<;eight 
was only about 5 grams during the observation peri odl in 
contrast to t h e neg~tive (noninjec ted) control animals 
whi ch g ained 41 grams during the same period of t i me . 
Arthritic rats showed a very significant los s c f weight 
during the first t hree days following adjuvant inj ection , 
after which a s lovJ 11 recovery" to preinj ec t i on weights 
occurred by day "12". Body we i gh t t hen f luc tuated over 
a narrow range during the remaining period of study . In 
this respect , · the resul ts obtained are similar to those 
of Glenn et a l . (35) and intermediate between thos e of 
- -
Pearson ( 36) who descJ: i bed normal weight gai n and Newbould 
(27) who noted severe weight loss in posi tive control 
group a nimals . 
The b o dy growth curves f or drug- treated arthritic 
rats (Figure20. to Figure26. ) indicate that among the 
nonstero ida l antiinfl ammatory agent s studied , ph enyl but a -
zone , mefenamic acid and indomethacin (at the dose levels 
employed) did no t significantly a l ter body weight re l ative 
70 
Table VII.--Effects of Drug Treatments on Body ~eight Gain in Adjuvant-Induced Arthritis 
~----------------~----------------------------------------------------------------------------Heall Body 'Weight ( gm.) 
Treatment Group Day 0 Day 3 Day- 6 I Dw.y 12 l Da_y __ 1...::;8~-D-a_y __ 2_l~~---D-ay----2-4---,,--D-a_y __ 3 __ 0_ 
l-----------------~--------4-----~--+-----~--~-------1 i Negative Control 228 232~ 234ii I 235.a I 253..£. 2531i ! 2SS.ii I 269il 
Positive Control 215 204 209 ! 217 ! 213 216 I ·212 220 I . I 
Cryogenine 220 215~ 217 1 222 ! 229 234.£ I 235~ 2/d~ 
. I 
Phenylbutazone 212 210 216 I 22 1 I 218 I 222 i 224 I 231 
!!efenamic Acid 217 212 215 i 2~3 I 227 226 I 229 I 236 
i . I I Indomethacin 216 206 205 I 2 14 I 216 219 I 224 230 
Paramethasone 210 190..§!. I 186~ ,. t~3~ i 191a. 190~ I 194 202 
llyd rocortisone 2 26 219~ 1 218 , 221 I 228 230 I 236!! , 244~ 
6-mercaptopurine II 218 205 198 198~ 201 
1 
139 ) 200 I 208 
a 











C>--0= mean body Yeight of positive cont:r-o1 anirr1als 
0--0= mean body vreight of cryogenine-treated animals 
Figure 20.-- Growth i mpairment in adjuvant-induced arthritic rats 
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l 190 _____ 5-- --12 --·--- "18~24--30-
o-<>= mean body '-'·eight of positive control animals 
8 e = mean body weight of phenylbut.azone-t~eated animals 
Figure 21 .-- Growth impairment in adjuvant-induced arthritic rats 
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'ti rnc (day s) 
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, 
o--o = mean body ·weight of positive control animal s 
0-G = mean body weight of mefenamic acid- treated animals 
... 
Figure 22 .-- Grmfth i mpairment in adjuvant-induced. arthritic rats 






























Q--0 = mean body weight of positive control animals 
~= mean body weight of indomethacin-treayed animals 
Figure 23 .-- Growth ,impairment in adjuvant-induced arthritic rats 
' 
treated "with indomethacin (1. 0 mg . /Kg.) 
.· 
". 
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o-o == mean. body weight of positive control animn.ls 
(t--(t = mean body weight of paramethasoue-treated animals 
Fi·gure 24.-- Grow;th impair ment in adjuvant-induced a.rthri tic rats 
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...._ __ 6 ----18~--24----30 
time(days) 
... 
o--o== mean body Height or posi t:i.Yc cont:o:ol animals 
8->-C= mean body weight of hyd.rocort.isone~treated. aE:i.mals 
Figure 25 . -- Growth impairment in a.djuvant:~indueed arthritic ra·::.s 
treated vith hydrocortisone (lOJ:'J.g./Kg . ) 























0-{)= mean body weight of positive control anima.ls 
f}---0= mean body weight of 6-mercaptopurine-treateo. animals 
Figure 26.-- Growth impairment in adjuvant-induced arthritic rats 
~treated with 6-mercaptopurine (2.0 mg./Kg.) 
vveight (gm) · 
1 250-i 
240J 
















190 .._ __ 6--12--18--24--30·-
time(days) 
to po si t.i v e cont1:·cl o.niwaJ.s. Cryogen.ine CJ.ct:ually 
promoted an increase in body weighl after terminati on 
of treatment (dcq "21"' to day " 30") ; this gain was 
sign.ificartt l y d i£fe1:ent (P 0 . 05) f roill that of n ont rea. t ed 
adjuvant- injec t.ed controls . In arthri t ic ra ts , 6-n~er.cap ·· 
topuri ne and paro.rr.e thascn c caused vJei ght l oss 1.vh.i le t he 
body wei_ght o f hydrocorti sone-treated anima.ls was signif-
icantl y greater than posi t:ive contro l a.nimals in the 
termination of the observa tion period (day "24 " thrm.l~.Jh 
day "30") . 
The therapeutic action of cryogeni ne and the selected 
antii nflammatory agen ts on adrenal , spleen and thymus 
wei ghts a.r:e surnmarized in Tabl1~ VIII. By the end of the 1 5 
day period , the inf lar.1matory process r.ad d eve loped to a 
s u ff i cient intensity to markedly i ncrease adrenal and 
s ple nic weights and to decrease thymus weights in positive 
cont rol group animals . These changes still p ersisted at 
the 21 day period . At the conclusio n of the 30 day 
observation period , however , the increase in adrenal 
weight was no longer so apparent, however , the decrease 
in thymus weights was observed to p ersist . 
Effects of C,ryoqenine on Previou.s.l..Y,~~b lished 
Arthritis ~-- Arthritis was induced in a number of rats by 
methods descri bed pr evious l y and a llowed to p roceed 
without drug tre a t ment unti l day " 21", at wnich t i me the 
animals wer e divided i nto two g r oups . One group recei ved 
only t he 0 . 25% agar o r a lly wh i l e t h e other was treated 
with· c ryogenine ( 1 00 mg / Kg , p . o . ) dai l y for 7 days . The 
Table VIII. 
Comparative E~fects in The Rat of Selec t ed 
Drugs on Wet Organ Weights in The Presence 
of Adjuvant-Induced Arthritis. 
I I I I 
Mean Organ Weights (mg . /100 ?,m. Body Weight) ! S . E. 
Day 15 Day 21 
rSpleen Treatment Group Spleen Adr enals T~wmus Sl)leen Adrenals Thymus 
Negative Control 247 1i.4 181 25'• 16 . 3 185 283 
!19 :!:1. 2 :!: 2 I :!:10 ±0. 6 ±11 :!: 9 
Positive Control 386 20.9 119 484 23 . 6 122 369 
±14 :!:1.0 ±1 3 ±32 ±1.8 ±14 ·t2 2 
Cr.rogenine 306 16.8 175 394 18 . 2 199 304 
±12 ±0.9 ±19 ±28 ±1. 8 :!:21 ±10 
Phenylbutazone 321 17.9 138 341 19 . 6 102 I 318 
:!: 22 :!:1./ ±28 :!: 22 ±1.2 ±18 I ±28 Indomethacin 370 22.1 1'•6 399 21. 0 182 318 
:!:54 :!:0. 7 ±17 ±27 ±l. /~ ± g · :!:63 
tviefenrunic Acid 369 20.0 11 8 460 21.8 90 400 
±36 ±2 ·'· ±19 ±46 :':1. 0 ±1 7 :!:32 
Paramethasone 176 10.0 68 223 11.2 130 270 
:!:18 ±1.1 ±11 :!:18 ±2. 1 :!: 8 ±66 
Hydrocor~isone 240 12.6 71 250 J 2 . 5 1l•O 286 
±28 ±0 . 7 
± 13 ±18 ±1. 8 ±29 '~ ±22 
6- Mercaptopurine 226 17.0 65 264 18 . 2 78 332 
±27 !u.S 
----- :!: -~- l __ ±17 -- - -- - ±~ --8-------~-=-- - _ ±3 2 
--- -----
- !_ __ - -------
Day 30 
i'.drenals 
17 . 2 
+(' ' 
-'J• J 
17 . 8 







18 . 2 
:t0 . 1 
14 . 6 
±0 . 8 
17.2 
±1.4 
18 . 4 
±0 . 6 










































r~sults of this study are shown in ~able IX. Cryogeni n e , 
when administered to rats with the est&blished disease , 
exerted a significant inhibitory effect (paw volume) 
within 4 clays f ollowing i ni tin.tion of drug treatment . 
Moreover, animal s receiving cryogenine showed a greater 
body we i ght ga:Ln dur:in9 t he treatment period than did 
the arthritic control grou p ; however , this was not 
statistically s i gnifi cant . (P>O.OS) . 
~~~biditl_ in...;Adj}~~~':..~.njes!:_~~~·--
89 
Figure 27• summarizes t he effects produced by the selected 
anti i nflammc>.tory 6 ::::-ug s on serum coagulation in adjuvant-
inj ected rats as reflected by comparativ e absorbancy 
determinatio ns (turbidity). Si gnificantly decreased 
turbidi ty values were noted in serum obtained from 
adjuvant-injec ted control group animals in comparison to 
vehicle treated (0 . 25 % agar) non-injected animals . 
C~yogenine , as well as most of t h e other selected non-
steroidal antiinflammatory agents all tended t o reverse 
this decrease in tur b idity towards normal control levels. 
Hydrocortisone and par&methasone trea·tment likewise 
reversed the decrease produced by adjuvant injection. 
Mefenamic acid and 6- mercaptopurine , at the dose leve l s 
employed were the lea st effective agents in preventing 
the l owered turbidi ty values seen in adjuvant-injected 
animals. 
Hematoloqica l Studies in Adjuvant-Inj~ted Rat~·-­



















Table IX.-- Effects of cr yogenine on esta.b,lishcd ad,juvant- induced artbritis 
Foot Volume; mL ±S • .b; . I l! hl)dy \.Jeight , gm. _ ±S, £. 
.. II 
l! 
Vehicl e Control s Cryogenine Treated 11 Jehicl~ Controls Cryogenine •rreated 
-- II -L R L R 
'I 
L 76 :!0 .12 2.58 ±0.03 1. 77 ±0.96 2. 59 ±O.i•4 I! 220 ±5. )~P, 221 ! 2. 55 
I I 
I 1.81 ±0.13 2. 67 ±0.03 1.74 ±0 .13 2.58 ±0 . 19 I: 221 ±6.10 222 :.!:2 . 78 I I 
b II l. 79 ±0.10 2.73 ±0. 04 1.80 ±0.13 2.47 ±0.03- I I 22li ±5. 87 226 :t3.19 
b II 
l. 92 ±0.11 2. 86 ±0.07 1.66 ±0.11 2.35 ±0 . 01-- I' 218 ±3 . 66 228 :!:4.13 
" 
b 1.96 ±0. 09 2 . 91 ±0.11 1.64 ±0.10 2. 29 ±o . o4- I I 218 ±3.56 230 ±3 . 9"[ I ' 
b b II 1. 97 ±0.10 2. 88 ±0. 08 1. 66 ±0 . 07- 2.19 ±o. o4- 221 ±2 . 56 230 ±3.1~( 
b b 1. 98 ..t0.09 2 . 97 ±0.14 1 . 59 ±o. o-r- 2 . 15 ±o. oa- 219 ±1 . 8'7 230 ±3.37 
b b 2. 05 ±0 .10 3.08 ±0 .13 1.65 ±o . o4- 2. 10 ±0. 09- 221 ±2.17 229 ±3. 35 
+16. 5% +19. 4% - 6. 8% -18.9% +0 .8 gm . +8 . 3 ~· 
No treatment for the first 20 days, followed o:r t:ryogenine (100 mg. /Kg./day) on days 21 through 2'7 

















Treatment GrouE Or al Dosa g~.L-!!!B._· / Kg . /Day 
A = Negative Control 
B = Positive Control 
c Paramethasone 0.5 
D Phenylbutazone 100 
E 
-
Mefenamic Acid 25 
F = Indo:ne thacin 1.0 
G = Cryogenine 100 
H Hydrocortisone 10 
I :; 6-mercaptopurine 2 
Figure 27 .-- Effects of drug t reatments on s e rum turbidity (absorbance , 
mean ±S.E. ) in adjuvant- induced a r th r i tic ~ats. Drugs wer e 
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I I I ' I I 
I I 
Effects of Drug Treatments on \Vhite Cell Counts i n Adj uvant- I nduced Ar t hritis 
Hean W.B . C. (thousands/ cu . mm . ) ±S. E. 
Day 6 I Day 15 Day 21 
19 . 3 ±0 . 8 15 . 4 ±0 . 9 17 . 3 ±1. 1 
24 . 7 ±2. 1 25 . 2 ±3 . 0 29 . 2 :!:1.1 
16. 6 ±3 ~4 18 . 3 :!: 1. 9 22 . 0 ±3 . 3 
21. 4 ±0. 9 22 . 2 ±3. 0 I r 24.4 ±2.0 
I 21.4 ±1.8 25 . 3 ±0.9 29 . 3 ±3 .1 
23. 3 ±3. 9 23 . 0 ±3 . 3 I 26 . 4 ±1.1 
21. 8 ±2. 2 10 . 1 ±2 . 3 13 . 4 ±0 . 3 
12 . 5 ±1. 1 I 12 . 3 :l:0 . 3 16 . 5 ±L9 
14 . 2 ±1.9 24 . 2 :!:1.1 I 26 . 6 ±2 . 2 I 
I Day 30 
I 15 . 3 ±0 . 9 
24.5 ±3 . 2 
. 20 . 6 ±1. 7 
23.9 ±2. 1 
' I 26 . 3 ±2.0 
I 26 . 1 1:2 . 3 ! 
! 
I 18 . 3 ±1. 8 
19.5 ±1.4 














Table XI.-- Effects of Drug Treatments on White Cell Counts in Ad_iuvant-Induced Arthritis 
Differential ~'hite Blood Cell Counts (Lytnphocytes, Neutrcpi.lils) I 
---1 I I 
Treatment Group Day 6 Day 15 Day 21 Day 30 I I 
Lymphs . Neuts. Lymphs. Neuts. Lymphs . Neuts. Lymphs. Neuts . i 
% % 0 ' % h o; I ~ % ; lo 
'2 I 
Negative Control 83 12 78 17 81 15 I 81 17 I 
I I 
Positive Control 51 43 56 43 53 37 63 32 I Cryogenine 68 28 67 27 I 66 29 71 25 
I I Phenylbutazone 65 30 63 35 I 68 28 74 21 I I I Mefenamic Add 57 39 52 42 61 31 59 37 I I I Indomethacin 51 47 57 37 65 29 63 33 
Paramethasone 46 48 49 47 49 4'· 61 33 
Hydrocort isone 42 53 51 45 57 39 I 73 22 I 
6-mercaptopurine 58 37 ?9 21 69 27 69 25 I 
--- ---- -- --
\0 
_::.. 
white blood cell responses to udjuvant.-:t.ncluced c:xthr:i.t.i.s .. 
It was evident that the adjuvant disease resulted in a 
biphasic increase in total white cell count which was 
associated with a relative lymphopenia and neutrophilia 
in positive control group animals . The first cell count 
increase \vas associated with the development of primary 
swelling in the inj ected foot, while the later i ncrease 
(Day "21 " ) was associated with the development of· 
secondary l es ions . Treatment with c.ryogenine and t h e 
other nonster oidal antiinflillnmatory agents appeared to 
offer only a moder ate degr ee of protection relativ e to 
the level of leucocytosis observed in positive control 
animals during the 30 day observation pe~iod. 
95 
The comparative effects of drug t r e atme nts on levels 
of sedimentation rates in animals injected with !,'lyco12_acte-
riumadjuvant are illustrated in Figure 28 · An increase 
in sedimentation rates was noted in positive control group 
animals within 6 days following adjuvant injection and 
was associated with the primary inflammatory response . 
A very significant (observed P= 0 . 01) elevation in sedi-
mentation rate:3 was observed on Day "15 " during the acute 
phase of the disease and on Day "21" when secondary lesions 
were fully manifested . These values continued to remain 
elevated for the remainder of the 30 day observation period. 
In adjuvant- injected rats, cryogenine , phenylbutazone , 
hydrocortiso ne and paramethasone were found to be the 
most effective of the agents tested in suppressing the 
t. 
A -,= Negative Cont!'ol 
. B = PositiVt! control 
c Cryogenine 100 
D .. Pher.y1but:azone ;_oo 
E = l1efenamic Acid 25 
F Indomet~1acln 1.0 
G Paramethasone 0. 5 
H--= Hydrocortisone 10 
I = 6-mercaptopurine 2 . 0 
Figure 28.-- Effects of drug treatments on erythrocyte aedimentation 
rate· i n adjuvant--induced arthritic rats . Dt'ugs \•Tere 
given orally for 21 days beginning one da.y prior to 
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increase in sedimenta t ion rale 1 since values tended to 
app.roach n or mal control J.evels. Mefenamic a cid at a 
dose level of 25 mg/Kg afforded little effect on 
s~dimeni.:ation rates in comparison 1:o positive control 
group c.nimals receiving no drug treatment. The cytotox.i.c 
agent, 6-mercaptopurine, decreased sedimentation rate, 
but to a lesser e:;.:tent than the nonsteroida l antiinflam-
matory compoundsk 
2. Q.!_t~ra.v:1_olet-:.!D .. duce_cl -~}]_~~ 
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'l'he efficacy of cryogenine, mefenamic acid, 
phenylbutazone and indomethacin in reducing or delaying 
the erythemic response to ultraviolet irradiation in the 
guinea p.ig is summarized in Table XII. The ED50 values, 
~nterpolated from log-dose response curves, represent the 
dose of each drug which was determined to inhibit the 
erythemic response by 50 percent in comparison to control 
group animals. At the dose levels employed, 6-mercaptopu-
rine was inactive. As noted by other investigators 
(37,70) the steroidal compounds, paramethasone and 
hydrocortisorre were essentially devoid of activity in this 
experimental mod.el o£ inflammation. 
3. Acute Cardiovascular Interactions 
Intravenous doses of cryogenine acetate were 
essentially without effect on mean resting blood pressure 
in the rat. Cryogenine in doses of 0.04-8.0 mg/Kg 
produced only a slight and very transient decrease in 
blood pressure immediately following ~njectiono Depressor 
I I 
Table .XII. --. Comp'lrativen eff'_ects of cryos._eonine_ o,n .):llt:ro.viJ:Ilf!t-:imluced eryth~,f;la i_n t_h_e wir:ea 'IJi,g 
Treatment 
Cryogenine 
• Oral Group inflammatory scores 
dose 
mg./Kg . 1 hr 2 hr 3 hr 




29 . 5 
16 6 . 3 1 7 o3 11.1 19 . 5 




1 64 2 . 7 4. 7 8 . 7 11.8 _ 
0 9 . 0 13 .3 14.3 29 . 5 
8 5.0 7 . 3 10 .7 17.7 
16 2. 3 · 1. 0 9.3 14. 0 I j 
32 1.3 3 . 3 5 . 3 7.'i J 
0 9. 3 13. 0 14 . 7 29 .7 ' l 
16 5.1 6. 3 11. o 11 . 5 . 23 . 5 1 
32 4. 0 I . 6.3 8 .7 14.7 I I 
64 0 . 1 2 . 0 4 • 3 4 • 9 
Phenylbutazone 
t-iefena.'llic Acid 
12 . 5 
Indomethacin 
o 10.7 I 14 . 0 14 .3 31 . 9 
2 6. 3 . 7 .3 11. 7 19. 5 
4 4. 3 I 5. 0 9. 3 14. o 
8 2 . 0 4.3 7 .0 9. 8 I 
3.1 
0 9.3 I 12 .7 I 14 .3 29. 2 1 
16 9 . 0 13 . 0 I 14. 0 29 . 0 
32 8 . 7 13 . 0 13 . 3 28 . 4 l 
I 64 9.0 l2,Q_-r 14 . 0 28 . 0 
0 10.3 12.7 13 . 7 29 . 9 
16 11.0 14 . 0 14.0 32 . 0 
32 9 .7 13 . 0 13.7 29 . 6 . 
I 64 8. 7 _ _]._3 . 3 13 .. 3 . I __ 2~ . 7 ~- --· • I 
0 9. 0 12.3 13 . 7 I 28. 2 I I 
16 9. 0 I 12 .7 14 . 0 28 . 7 I -- I 
32 8.7 11 . 7 12 . 3 26 . 6 I 






responses to bradykinin , histamine and acetyl chol ine 
challenges were only slightly altered from control levels 
followi ng cr:yogenine treatment ''Jhile pressor responses 
t o epinephrine chall enges were or1ly slightly reduced 
(Figure 29 . ) . However , cryo9enine at doses of 4 . 0-8 . 0 
mg/Kg suppressed the depressor response to test chal lenges 
of serotonin approxima b'=l Y 20 to 25 percent froro control 
l evels . 
4 . Q!_':!_g;::Il2(~ .. ~!.£~L~:.:-<?_~Ch££~ tEic tion 
I n guinea pigs prepared for recording r esistance of 
the lungs to infl ation , control reference challenges of 
bradykinin were administered intravenously in doses 
r a ng i ng from 0 . 5 to 1. 0 meg/Kg . In al l animals these 
doses of bradykinin increased resistance t o inflati on to 
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a marked degree . Reference to Figure 30 . indicates that 
t h e response to bradykinin differed from those to his~amine 
and ser otonin in i ts s l ower onset and longer duration at 
or near peak l evel s . The bronchoconstri ctor acti on of 
bradykinin was found to be essentially unaffected by 
int ravenous doses of cryogenine ( 5-10 mg/ Kg) admi nistered 
5 to 20 minutes pri or to the bradykinin challe nge doses 
wh e n c ompared to control refer ence responses . 
Re s ponses to histamin e (2 .0 me g / Kg) obtained i n t he 
s ame manner , were often variabl e fo l lowi n g cryogenine 
pre treatme nt ( Fi gur e 31.). Generally , h owever, litt l e 
change from contro l responses was noted. 
.. , 
.. 
Test Chal}.9_ng_e_s __ _ 
Dra.dyki nin 10 mcg . / Kg . 
. .. Histamine Dihydrochlori de 6 meg. /Kg. 
Acetylcholine Chl oride 4 mcg./Kg. 
, Epinephrine Hydrochloride 2 mcg./Kg. 
.. 
. . 
Serotonin Creatinine Sulfate 2 mcg./Kg. 
. ·, 
Figure 29.-- Acute cardiovascular interactions of cryogeninc in the 
.. anesthetized rr...t. (mean respons e / 2 detennin::1.tions) 
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-10 ---.,;---~ 
__ S_e_. ro toni!}_ 
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_L_ 
Elapsed Ti me in Hir,u tt:s 
0.04 0.4 4.0 8.0 mg./Kg. 
I I I 0.04 0.44 4.44 12 . 44 
0 
C'ryogeni.ne Dosag~"c::..+l------+------ll------+------1r-­
Cumulative Dosage 0 
'l'op ~Ol.v : 
}'~iclcllE.' f\c';~ ~ 
Bot tom I~ ow : 
~ =-=- B~::-c>.dyk5_n.tn 0 .. 5 m·.: g .• /Kg .,. 
!It ... JJ;,.. ·- Cryo.:;;erd.n2 1 C .. 0 Ti:tj .- / Kq ., 
~ = Bradykinin 1 . 0 mcg . /Kg . 
A :.:: Cryogs=mine 10., 0 mg ./Kg . 
Figure 30 ,.*·- :Cffec-t of c.r.y-ogenine on bradykinin- induced 
bronchoconstric t ion in the guinea pig 
101, 
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Cryogeninc~, injected 5 to 25 minutes befor·e challenge 
doses of serotonin (1.25 meg/Kg) consistently enhanced the 
bronchocGnstrictor effect of the challenge dr:u.9 to levels 
.f.r.o.m h;o t o three · times t hos2 of control refe.1.:-ence 
responses (Figure 3 2 .. ) • 
Cryogenine was administered i n traarterially during 
continuous preganglionic stimulation at frequencies 
ranging from 0.1-1.0 cps .. F'ollowing injection of t h e 
drug, ganglionic transmission was monitored continuously 
for a period of 2 hours. Cryogenine (50- 750 meg) failed 
to produce any d~tectable changes in either spike 
a.rnpli tude or afterpotential contour- evoked by sup::-a.maximal 
or submaximc:tl pregaPglionic s timula tj_on. The submaximal 
stimulation was determined by selecting t hat voltage 
\·1hich vmuld produce a ganglionic spike one-half the 
ampli tude of that obtained Hi th supra.maximal preg·anglionic 
stimulation. It was deterrl}ined that cryogenine (50-750 ),!' 
meg) did not ~voke ganglionic firing. Moreover, no changes 
in the resting demarcation potential were observed as the 
result of cryogen{ne administration. Similarly1 there was 
no evidence of asynchronous postganglionic discharge 
evoked by cryogenine (750 meg) in ganglia conditioned by 
repetitive supramaximal preganglionic stimulation (30 cps 
for 30 sec.) or in ganglia pretreated with isoproterenol 
(2 meg). 
' Tpp · Row: l !, I ' • ..-.. 
I 
0 = Serotonin 1.25 mcg./Kg~ 
A= Cryogenine 5. 0 mg./Kg • 
. ' 
Bottom Row: 
.0= Serotonin 1.25 mcg,~/Kg. 
A = Cryog8nine 10.0 mg./Kg. 
Figure 32 .-- Effect of Cryogenine on serotonin-induced 
bronchoconstriction in the guinea pig 
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Ganglionic discharges evoke d by acetylcholin~ 
(10 meg) , DMPP (5 meg) , 5- H'l' (10 meg) or KCl (500 meg ) 
were unaffec t ed by cryogenine (750 meg) administered 5 
or 60 sec . earlier . 
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The postganglionic f i ring evoked by the intraarterial 
administration of THA ( 5-1 0 meg) was not modified in 
ganglia pretreated with cryogenine 15 sec. earlier . 
Furthermore , the biphasic ganglionic demarcation pote ntial 
produced by TMA ( 10 meg) and Dl\1P P (5 meg) was unaltered 
by the previous admini stration of cryogenine (750 meg) .. 
The postganglionic firing pr oduced in response to 
physostigmine (200 meg) , oxotremorine (75 meg) ., 
methacholine and McN- A- 343 (25 meg) was una f fected by the 
administration of cryogenine (750 meg) prior to or during 
t he evoked asynchronous discharges .. More over 1 there were 
no apparent alterations in the enhanced level of firing 
evoked by these agents in ganglia pretreated with 
isopr oterenol ( 2 meg ) or i n ganglia conditioned previously 
by repetitive supramaximal preganglionic stimulation 
( 30 c ps for 30 sec . ) . In addition , cryogenine (750 meg) 
f ail ed t o prevent the complete abolition of the 
"mu s carinic" firing that occurred almost immediatel y 
following the administration of atropine (2 meg) . 
I n gangl ia pretreated with cryogeni ne immediately 
prior t o or 30 sec. before inj ecti on of DMPP (5 meg) , 
TMA (10 me g ), l evar tereno l (O . S ~ mcg) , epinephrine (0 . 5 meg ) 
or methacholi ne (50 meg) , no observabl e antagonism or 
enhancement of U1e ganglionic blockade produc~d by these 
compounds was noted . 
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DISCUSSION 
A variety of biologic techniques and e x perj_mental 
approa cr.es :1ave been employed to discover potential 
antiinf lc..mrnai.:ory drugs "for the treatment of human 
connective tissue diseases . To this end 1 there have 
been nurne~cus attempts to produce an arthritis-like state 
in -labor a tory animals during the last seventy year:s . Tn -
1960 , Gardner ( 38 ) reviewed and classified these attempts 
to artificially induce arthritic and inflammatory states 
by the various means employed : (a) infective agents , 
(b) chemica l agents, (c) alterations of endocrine 
mechanisms 1 (d) immunological and (e) p!1ysicol methods . 
I:n 1937 7 Freund et al . (39) published their method 
of sensitizing guinea pigs and rabbits by injection of 
killed tubercle bacteria. In later work , when the 
organisms were suspended in mineral oil and injected, the 
se~sitivity and antibody titres produced were found to be 
mar-kedly increased . Subsequently, this method was observed 
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to p.::-oduce an arthritic--like condi t:ion in rats . 'rhe 
rniner.a.l oil 's adjuvant function as the carrier of the 
I"lyc,'2_~~:£!.~:b::.!J.!:. is unknO\oJn . However , it has been suggested 
t.hat Jt may aid in clisserninaJcion from the injection site, 
prevent dest.ruction ar:.d p.r.otect the dead organisms from 
phagocytosis (56) • . Since that . 'l:ime , numerous investiga-
tcrs have shOt·m that a single injection of Freund 's 
e.C.j uvant (containing any one of a n•.1mber of species of 
l:!Y.~~te~) will produce a chronic ., local and migratory 
inf'lammatory response in the rat (27 735 741 -44) .. The 
lesicns whlch subsequentl y develop involve not only joints 
and surrounding tissuE': ( synov:L tis 7 periarthritis , 
spondylitis) , but also skin (nodules of ears , feet , tail) 
and. eyes (conjunctivitis , keratitis) (45 ) . The disease 
has many simi.la:d .ties to ri1eumatc.2.d arthritis and othe!:' 
connective tissue disorders which occur in man . Thus , 
the polyarthrj_tic syndrome in rats has become one of the 
most important rnocels of inflammation for the study of 
potentially useful steroidal and nons teroidal antiinflam-
matory agents . 
The etiology of this arthri tic disease in rats is 
still unknowG (46 , 47) . However, a body of indirect 
evidence is accumulating which indicates that an 
immuno log ical reac tion to unknown constituents of the 
tubercle bacilli may be involved . 
i. Th e experimental d isease can be transferred 
to normal rats with viable l ymph node cells 
Oi)tained :f.rom sc::n~>i i..-.ized don.or rats o:f the same 
inbred stra.in (·H i ) • 
~~w Induction of tolerance to mycobacterial antigen 
in the neonatal period (before 5 weeks old) can 
inhibit subsequent p.r-oduct:Lon of the disease 
(48 , 49). 
iii.There is a charact.eris1:ic 10-l.S day latent 
period to the onset of po l yarthritis (41) . 
iv . Ant~-rat-l~nphocyte serum inhibits the appearance 
of arthritis (50 , 51) . 
v . Whole ~ody irradi ation or the administration 
of corticosteroids will suppress the arthritic 
condition (41 ) • 
The possibility that an infectious agent is respons ibla 
fer the pathogenesis of this disease is generally 
considere~o be unlikely since the d isease can be induced 
in gnotobiotic r ats and its course is not influenced by 
massive pretreatment with penicillin, streptomycin or 
tetrasycline (41 ) • Moreoever 1 at the sites whe.!:'e secondary 
lesions arise , tuberc l .e bacteria or their constituents 
cannot be demonstrated . Mycoplasmatacea (PPLO) and the 
activation of a latent virus by an immune reaction have 
been inferred by some investigators to be responsibl e for 
initiating lesion formation , but as yet , this has not been 
proven (52 ,53 ) . 
While the responsible antigen has not been identified , 
lJ5 
l t: 
,Jone s and Ward (5'4) havE:~ shown tha t "'c l abelled rnyco-·. 
bac te::ia suspended ln mineral oil are rapidly di ssemin<.i ted 
after intraderma l injec t ion <3-nd can })e fo,...tnd in l ymph 
nodes , spleen and periarticular tis sues within a f ew 
hours after injec tio~ . It is also possib l e that antige ns 
' 
other than those i ncorpo.r.c. ted into the a djuvant could be 
evoked. Tissue an·tigens al: the depot site have, hm.;ev e ::.:- 7 
been excluded by inves tigc. tors who have shcvm that r ernov a 1 
of the inj ection site (the t ail) within s evPral hours 
after inj ection with adjuvant does not influence the 
development of polyarthritis (55 ) • 
£!YC0.2.~cteriu~-induced art:hri tis is a disease peculi a r 
to rat s. Glenn and Gray ( 56 ) were unsuccess fu l i n 
inducing the disease in hamsters : mice , gerbi ls, guinea 
pigs, or rabbits. Similar attempts to produce the disease 
in boar s, male monkeys, dogs and r oosters were likewise 
without success . The arthriti s is p ermanent ly C.eforming 
because of the extensive connective tissue involvement. 
The initia l reaction of edema and soft t i ssue 
thickening at the injection site is probabl y due to the 
irri tant effect of adjuvant, whereas the la t e onset 
disseminated polyarthritis and the late swelling in the 
injected foot are presumably i mmunologic events. Different 
rat strains vary somewhat in response to the induced 
disease; hm.;ever , neither sex dif ferences nor thymectomy, 
splenec t omy, : bile duct ligaticn , castra tion or pregnancy 
alter the course or incidence of the disease. Adrenalectomy 
.:md bypop.bysec 'l:o~ny !~E·s ult in :jeath soon after acljuvanL 
administration (56). 
l..l6 
M.any methods ernployt'.: d in the pharmacologi::: screeni ng 
of antiinflammatory agent:.s utili ze lhe a.cu'L:E~ in:f1 arnrna.t: :i. o n 
produced by the inj· ection of rna terials suc h as dex t.ran , 
formal~n, yeast, silve r n itrate , c r various suspected 
media tors of inf la:nmation and other agt':n ts ·t oo numerous 
to mentior:. here,. Unl~dcc the infJ.amma tor:y ::>ynd:come 
associated with connective tissue disorders such as 
rheumatoid arthritis, the inflarmnah>cy .:: e spcnse to the 
above injected agents is usually transitory and is 
relat i vely i nsens::. tive to clinically useful antii.:-J.f l a.mmc.tory 
drugs except at near toxic do s e s (57 ). 
Other infla•nnc;. tc ry 18sioris prod'.!ced by sus tc--:ined 
s timuli 1 such as the ::;ubcu taneous i:nplantation of cot -ten 
pellets or tlte use of various granuloma pouch techniques 
are sensitive to antiinflammatory steroids but relatively 
insensit~ve to ~onsteroidal a gents (58) . 
Although there is some di's ;.:tgre emeni: regc:rding the 
etio.!:..ogy and nature or CJ.dj uva.nt: disease in rats, many of 
the co:upounds which h?..ve been proven useful in the 
trea·tr:-~ent of arthritis in man have shown activity against 
one or rr.o.:-:-e of 1.::he manifestations of the adjuvant disease 
in rats . These include both steroids and nonsteroids and 
va:cious immunosuppressive agents (27,53,59,60) . Adjuvant-
induced arthritis in rats resembles rheumatoid arthritis 
in man more than any other model of inflammation in current 
Methods used to measu.t::'e inflainmatory mc>.nifestatians 
i n t he a r thritic rat a re extremely impo~tant . Numerous 
s~tb.i er:.:tiv.: scoring sys terns have been devised .. '.i'he 
magnitude of the swel l ing of paws has been determined 
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by meas'Jring the circurrderence of inflammed limbs or 
by determi~ing the thickness of hind feet with calipers 
(27) . 'I'he edem .3.tou~ response , however ~ is frequently not 
uniform and is often not localized in the areas being 
measured . Furthermore , these methods are a l so partially 
stlbj ective ~~Ihen j udging the uniformity of pressure to be 
exerted by the calipers on the soft tissue .. I1oreover , 
the possibil i. ty of aggravating the inflammed t.i.sS 1J.es exis ts , 
especi a lly in chronic studies \vhich require repeated 
measurements . I n the present study, the plethysmographic 
de~ermination of paw volume was used to ev·a-luate the- -
activity of antiinflammatory drugs . Emp l oying this metl1od , 
\Vinter and Nuss ( 59 ) were able to obtain accurate , objective 
a!ld reproducible results related to log- dose administration 
of drugs . Furthermore , the high level or pr ecision 
obtained with this system of measurement permits a 
statistical treatmen·t of data not possible by the other 
means . 
The resul ts of the present study show cryogenine to 
be effective in s i gnifi cantl y suppressing the deve l opment 
o f adjuvant- induced arthritis in doses which appeared to 
be devoid of any toxic effects . Rats treat ed with 
cryogenlne during the course of the a1se~se remained 
conspi•::uous ly heal thy ~vhen compa.red to t he posj_ tive·-
control animals which lost wei.ght, developed coarse 
ruffl e d fur and generally appeared ill. In addition, 
more spontaneous activity and much l ess irr:Ltability ~-;as 
observed ln rats treated ~-:ith cryogenine. In the present 
experiments , untreated ra t s began to fight and vocalize 
and· assume defensive "f:tgh t ing" postures 11'Jithin a week 
after adjuvant in~ection (56). As the course of the 
disease pJ~ogr'=ssed this type of ac t i vi ty became more 
eviden-c. Such b ehavior was noticeably absent in rats 
treated ~.-:iily with c:::-yo·~enine, an observation tending to 
co:1.£i.rm the early reports of the mild tranquilizing 
properties inherent ~~ the ctrug (13) . 
In th1.s investigation, test drugs v:ere adminis te:ced 
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in doses vihich had been previously found to be optimal 
using other antiinflammatory testing procedures in our 
laboratory . None of the agents tested markedly prevented 
the s1-welling of the injected paw immediately after adjuvant 
admin~stration; however, an early arrest of swelling (but 
not reversal was achieved by cryogenine and most of the 
other therapeutic agents . Mefenamic acid was an interest-
ing exception . 
injected paws 
In addition, secondary lesions in non-
Cas well as ear and tail) were markedly 
i nhibited by all of the agents studied during treatment . 
Noreover, a relatively long lasting ~ntiinflarnmatory 
effect was observed after termination of treatment with 
l l.9 
cryogenine , pararne thasone, 6-mercaptopuri ne and 
phenylbutazone, while animals treated wi th indomethacin 
and mef enamic acid showed some relapse when treatment 
ended. In additior1: cryog enine produced a weighi: gain in 
a nimals in which the d i sease was allowed to deve lop for 
three 1..reeks before tr-ea tment \vas ini t i a.ted ,. Hor e over, the 
swolle n ±7eet; tn these rats actually regressed wi thin tvJO 
days of treatment with the alkaloid . 
Pollmving injection of adjuvant into a .rear paw 
there 'l.vas svJellin9 accompanied by ulceration and sometimes 
sloughing and hemorrhage at the inj e c t ion sitey These 
manifestati on obviously added to t he anbnals ' general 
debility . Noreover,- there \vas an abrup·t decrease in body 
weigh t just prior to the appearance of secor..dary lesions . 
Measurements of body weight during and after drug treatment 
inaica ·ted t hat among the nonsteroida l antiinflammatory drugs 
which significantly suppressed the polyar thri tic condi·ticn, 
onl y crycgenine was effective in permitting a partial 
res t oration of the normal rate of body weight gain. 
Recent reports by Newbold ( 61) and Piliero et ~· 
(62) suggested that a biphasic increase in leucocytes 
occurs during the deve l opment of adjuvant- induced arthritis . 
The resu l ts of the present study confirmed that ari. initial 
r ise in leucocytes. did take place and was associated with 
the p h ase of primary swel l ing . A sub sequent rise in 
l e u cocyte coant was a l so c onfir me d and thi s rise is 
as s oc.ia ted wit~ the developmen{: of the secondary lesions . 
• 
Our results also revealed a persistence of the leucocytic 
response throughout and (probably) extending beyond the 
30 day observation periodo The beneficial effects of 
cryogenine were evidenced by the fact that little change 
:from normal levels occurred during drug treatment .. The 
therapeutic efficacy of cryogenine was also evident in 
120 
the differential white blood cell counts . In control and 
drug-treated rats, the increases in t otal leucocyte counts 
~to~ere due primarily to increases in the number of neutrophils , 
~t;hich 1,.1as correla-ted \...,i th a rela. ti ve lymphopenia and 
neutrophilia . Cryogenine was again the most effective 
nonsteL·oidal agent in mod ifying the ratio of polymorpho-
nuclear leukocytes to l YTnphocytes towards norr:'!c.l . In 
addition to an absolute leucocytosis , arthritic c ontrol 
animals exhibited the classica.l respo:1ses to stress --
including adrenal and spleni.c__hyper trophy and t~ic 
involution . The therapeutic efficacy of cryogenine in 
·suppressing this apparent adrenocortical overactivity was 
manifested by adrenal and thymus weight.s in adjuvant-
treated animals which were not markedly d ifferent from 
those of control animals without adjuvant .injection. 
Cryogenine differed from paramethasone , hydrocortisone 
and 6-mercaptopurine in that it did not prevent splenic 
enl argement during drug treatment . Both paramethasone and 
hydrocortisone caused involuti on of the adrenals , no doubt 
due to their ACTH "bl ocking " action . 
These studies also reveal ed an i n crease in the 
e.ryt~1rocyte sedi.mentation rate that paralleled +.:he ris~:s 
·found in total leucocyte cou nts in adj uvant- inj ec ted 
animals . It is interesting to note that sim iltlr chu.r:.ges 
have also been observed in patients with rheumato i d 
arthritis (63, 64) . Cryogenine and most of the therapeutic 
agents t ested were signifi cantly protec tive against this 
manifestat ion of the inflammatory ~esponse . While 
increased s~dimentation rate is a nonspecific r eaction , 
this metameter appears to be a rathe r c onvenie nt and 
vclU~)le index for assessing the the rapeutic effic~cy of 
drugs in this model of inflammation becaus~::: of the small 
amount of blood sa.-nple needed a nd the :cela ti vely minimal 
EX?ense in b o th time and equipment . 
12.1 
In a recent study , Piliero and Colombo ( 65 ) investiga-
ted the action of antiinflammatory drugs or: the lysozyfile 
ac tivity and turbidity of serum from rats l-Jith adjuvant 
d i sease . Increa.sed l ysozyme l evels and decreases in serum 
turbidity (as determined by the stabi lity of serum protein 
against heat denaturation) were found to have an excellent 
correlat ion wi th the severity of t he various rr.anifestations 
of the polyarthritic condi tion. Treatment with various 
ther apeutical ly useful agents produced a rever sal of effect 
for both indi cators of infl ammation . ~'./e issman ( 66) has 
propose d that degradat ive enzymes r eleased from l y s osomes 
may denature the nati ve consti tuents of cell s of conn ective 
tissue . These denatur ed products may i n t urn i nduce a n 
in~une response l ike that seen in adjuvant- induced arthritis . 
12/. 
.Studie s of lysozyme activ.i t.y of su.pe~·natants of homoge na t e s 
of infl <.>.rm.1ed paws :from Fir' thri. tic r a ts revea led very 
significa nt activity relative to noninfl a mmed p aws , where 
there was virtually an absence of lysozyme (65) . The 
mechanisms wherei:Jy antiinflammatory agents inhibit 
lysozyme activity are essen t .ic>.l}.y unknown ; ho1r1ever , i t 
has been sugge sted tha·t infla mmat ion is de creased by 
substances that stabilize lysosomal enzymes 1 inte r fer e 
with the formation of antigen- a ntibody complexes (which 
upon ingestion b y leucocytes, could release lysosornal 
enzymes) or inhibit the migra tion of lys o some - containing 
white cells to a reas of inflammation (67,6a). Whether 
the decrease in heat-induced serum turbidity is directly 
related to elevate d l ysozyme activity is unre s o lved as 
yet; however , it is of interest to note that t he revers als 
i~serum lysozyme levels produced witn antiinfla~~atory 
drugs correlate well with those seen in serum turbidity . 
The prese.nt inv estigation confirmed the observations 
of Piliero and Colombo (6?) in that doses o£ the steroidal 
and n onste roidal drugs which effe ctively suppress e d 
inflammatory manifestations of a djuvant- induced arthritis 
also produced significant reversal e f fects in s erum 
turbidity towards normal l ev els . Cryogenine was shown to 
be essentially equipotent to phenylbutazone in this reg ard . 
2 . Ult.ravi~~duced Eryth.~ 
One of the more widel y used techniques for anti-
inflammatnrt screening is that of u ltraviolet- induced 
erythema i n the 9uinea pig . 'T.'his method was originally 
introdu6ed by Wilhelmi (69) . The vascular response of 
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gt<inea pig skin ·to u l traviolet light has several components . 
·An early histamine and/ or serotonin- mediated phase of 
i ncreased vascular permeability develops within 2 or 3 
minutes , l asts for about 10 mi.nu tes and is folJ.o•,.;ed . af ter 
about 1 hour by the appearance of erythema ( '70) . This 
increase i n capillary permeabili·ty provides a rapid and 
sensiti ve means for detecting nonsteroidal antiinflammatory 
agen ts since there is a good empirical correlation beh;een 
the abili ty of a drug to del ay development of erythema and 
i ts antirheumatic action in the clinic (31) . I t shou l d 
be noted , however , that a number of v asodilator and 
· gangliopleg.ic drugs which are active in this test, h ave no 
c l inical utility in human r heumatic d i sease (71) . Moreover , 
c orticosteroids are inactive in this_scr_eening proc edure 
(31). · The resul ts of t h e present study confirm t he an~i­
eryt hemic actions of phenylbu tazone, mefenamic a cid and 
i ndomethacin a nd a lso show that cryogenine possesses 
s ignificant a n t i-erythemic efficacy . Phenylbutazone was 
determined to have an acute (oral ) potency approximately 
3 times that of cryogenine i n this procedure . 
3. Acute Car diovascu lar Interactions 
Previous reports have indicated that in vitro cryogenine 
inhibits s mooth muscle contractions elicited by ace·tyl-
choline and suspected mediators of the inflammatory 
r e s ponse (histamine , serotonin, bradykinin) in a non-
competitive manner ( 1 3, 14) . Ear l y cardiovascular studies 
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b y Robichaud ~ .!?-1 .. ( 12) conducted i n the nog and cat 
demonsi:rated ct7oqenine to have little ei:fect on resting 
blood pressur e. , hor,.Je:ver , a later study by Kap l an !:.t .~l · 
(15) i n o n e dog showed c r yogenine to s.i..gnifica.ntly lowe r 
r esting b l ood pressure . Drugs affecting cardiovascul a.:r 
' 
integr.i ty al.~e known t o alter inflammator y respons es i.n a 
n onsp ecific manner and thus cannot . be regarded as true 
a nti i nfl ammatory agents. Gar a ttini et a~... ( 7 2) demons tra· ~· 
t e d t hat hypotensive drugs simulate significant anti-
inf l ammator y a c tivi ty especially in those tests utili zing 
r a pidly deve l opi ng edema formation. 
Th e present study indicated that cryogenine 
essentially is devoi d of any effeci:. o n resting blood 
pressure in the r c>, t at th-= .r.el<i ttvely hiqh dose l(~vels 
employed . Moreover , onl y equivocal variations in respons e 
t o histamine , acetyl chol ine 1 epinephrine n.nd ~radyk:in.in 
cha llenges were observed. The onl y signif icant card.io -
v a s c u lar flndihg was the progressive i nhibition of the 
s e r otonin-induce d depressor response . The pharmacological 
s ignificance of ·(:hj.s effect: , however , is obscure at this 
t i me . 
One o £ the more inter esting methods for eval uating 
the antiinflammatory a~tion of drugs i s to t est them as 
spe cif i c inhibi tors of the acti o ns of the s u spected 
humo r a l mediators of i nfl ammation. Bradyk i n i n . has been 
implicated .i n t h e e arly stages of t he ac~te i n f l ammatory 
process beca.use it pr')duces vasodi let i:-.ion~ :i.ncrea::;es 
capillary permeabili i:y 11 causes edema and leu cocyte 
infil·i::ra tion and e l .i.ci ts pain ( 73).. 'I'his implica 'l:ion i s 
further supported by t.he observation tha t bradykinin-
induced bronchoconstriction in the guinea p ig is 
antagonized by re. large r.uTI' . .ber of clinical l y usefi..1l 
antiinflammatory agents ( 74) . However , bradykinin 
antagonism b y antiinflammatory agents cannot be de:non-
stra ted in many other i!}, y_].v_~ preparations (rat blood 
pressure , edema and erythema in guinea pig or rabbit 
skin, rat uter us contractions ). Because antiinflc.il'Lrna tory 
agents i nhibit only the effects of bradykinin on :;jl.<inea 
pig bronchi but not on o·ther organs; Collier ( 75) has 
proposed that t h ere ar e two receptors 'for b r adykinin., 
As no·ted previou sly, a close correlation fer nonsteroidc:.l 
inflamrrra tory agents has been obsen:red- bebveen potency in_ 
delaying g uinea p ig skin e rythema after exposure to ul t ra-
violet irradi ation and activity against rheumatic diseases 
in man.. T1on~over , pote ncy in delaying ·t he ery·themic 
r eponse has been correlated with that of antagonizi ng 
bradykin in-induced brochoconstruction in the guinea pig 
(7.4). For these r easons , it was of interest t o determine 
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to what exte n ·t cryogenine would interfere with the 
bronc hocons t ricto r action of bradykinin ~ The r esults of 
this study demonstrated that c;:-yoger:.i ne failed t o antagonize 
the bradykini:1.-induced increase in !::'esis tance t o infl ati on 
o f guinea pJ.g lung s .!E. Y.~1 in this way cryogenine differs 
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f':l:-om :i.ndome thocin, mefena.mic: acid and phenyl:J~l tazone ( 4·1) T 
s .. Ganul:Loni ~ Tni:-erac U 0ns --~~·~-----·· -... -·--~ ... ------···-
In one of the first papers p ublished on t h e 
p h a.rrr.acoJ.ogy of cryogenines Robichaud ~ ~1-. • ( 1 2 ) 
reported that i:he intraperitoneal administration of 
c ryogenine would produc e mild hypotherm.:i.a 7 decreased 
motor ac·tiv l. ty , mydriasis , skin blanching u.nd p i lomotor 
erection in unanestheti~ed rat s . At rel a tively low non-
a t;a.x.i.c dos·age levels y Robichaud -~.t ~~~· (13) noted that 
c ryogeni;:'lc \vo·.lld sel~ctively suppress conditioned 
avo.i.dance responding ., in both discrete and continuous , 
avoi dance-esc=..pe situations . Cardiovascul ar studi es in 
the anesthetized i ntact dog and cat demonstrated a 
s igt}.ificant blockade of t he pressor r-:-~spc:nse to ex ogenous ly 
a dmi nis-!:ered epinephrine with doses o:f cryogenine hc.ving 
n o apparent effect on resfing l5loodpressure (12 ) . How-
eve r , kinetic experiments o n various isolated tissue 
pr epar ations demon strated a n appar ent lack of speci f i c i ty 
o f c ryogenine for the commonly employed choline rgi c and 
a drenergic receptor systems (14 ?15 ,17) . Robichaud a l so 
s -tudied the effects of cryogenine in two cats using the 
c l assical superior c ervical ganglion- n i cti tating membr ane 
prepar ation. Al l drug injec t ion s were made ~ the femoral 
vein a nd drug was a llowed t o c umul ate i n t he ani mal until 
death resul ted . No ganglioni c blockad~ was seen i n one 
cat u p t o the time of deat h , while a 50 per cent bloc k ade 
was s een i n t he other animal. Therefor e , i t was of 
l~o t r· ."'"" . . ',1 ,')c.·r~~ . .. ' :··l e' r ·'tCl '"'"S. r c.· S '"" ,., ,. 1.:c · +- ' · · .. - • • :1 c ; • · ·'- - ~ "- .t )~ :> ,; ;;. p ..: .- . c !l:f S c:U:l s.J . .J. HlJ.C ac ._ J .. V ~.-r:y 1 
sincE.~ such r-~.ct.i vi t.y c ould p r.oduc:e fa 1se- posi t i v e r esuJ.-t:s 
metabo .U.c b r e akdov.r1: p1:oJ ucts o £ c:r·y ogCc~nine .. Vvhile t .he 
l upine alka.l o idE may po.s s ;;:.::::s a n ic:o t 2.ne-J.ik:e commo11 
d e n om.i.n.a.b)r., sev e r a l j _nv e£.: 1.::i.C_2 3. t o r s h av e clemo n~:; ::rate d 
distinct diff e rences b e t ween u~m a nd cryo genine in 
r egard to card iov c:.sc u.l ar:- , r.::n t i.in.flamm <i t ory 1 <inC. r;:,;y c ho-
phar:ma.co l ogic ac U:·.;i.t:y { 1 3 ,15,76) ... 'I'his sr.ud y sup por t ed 
these c o r1clu s i ons sine ~"! c J:yogeni ne 1rh l S e ssential l y 
f ') ·~ 
.:. .:. / 
CONCLUSIONS 
1'1os t ;.ud.:iinf""lam~ua t o ry dr'...:Sf:3 c!..'='e :u::idic compounds; 
therefore , the efficacy of crycgenine ~ a n a l kaloidal 
]:) aS<-~ : i s of rnore -than rou tine interest . Although 
cryog'O' rli ne .1 s s t .ru.ch1rally u nre:la b~d to e.ny ot.her k.;--_c ~·m 
r 1 ·:1 5 c: r f-" · ., ·:- .; ·' n i= 1 ·~ ' "' ·t · · 
···-.< -- C)- d •. ..... .! . . . <- . v.m.nr.·. or. y 1 ~ntip~retic, or analgesic 
a.:;ents it :Ls effective in ce.rtain ex p e rir.·,enta l in17 lr::t!i•~a-
to !: y c ·::mci t:ions which r esoond to the r.ni.tiinflamrr.a tcry 
c~ruqs presently i n c linical -u.se . ~h·~se models of inflar-1111a.· .. 
tioh include : adjuvant- i nducej ari:r:ritis , ultraviolet-
ir~(~uced erythema (indica ted in our studi e s) a s we l l as 
caraqeenin- induced edema , peptone- induc e d fever , and 
·histamine - .:.r:dt:ced intradermal '.vl":ea l .s (noted in p.r:evious 
studier. (15)) . 
Cryogenine is acti ve in inhibiting various suspected 
mediators of i n f lammation in smooth ~uscle preparations 
(histamin 8 , &c e tyl c holi ne , serotonin , bradykinin ). More-
ov er , c ryogenine possesses some selective central nervous 
syste m depre ss a nt acti vity . Its nonspecificity of action 
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j 'l. '·) 
2a·' ~ ··1~ t · ~-he common .. 1euro- a.nd tis .sue- · hormo n r.::s 
- -· O..l.' .:.• - '-· ·- - • • . 
that :l.tE anti.inflamrnatory eff12cts u.l:'e not relc:-. ted 
pr~m~rily t o the inhibi tion of acu te pha~e re~c~2nts . 
Invol vement of the p it 1..d t a.r:·y·-ad!.'(:!rw.J ax:U; in i.: iv:~ 
Adrena1 a't'td thymu:;; weights 1 w~·d.c:h <3Xt:~ s e n2l t:Lve j_nrli c::t tors 
o£ ad1.~.enal s t i mu:!.a t:Lor, , t~..3s en tial J.y .cerna..Ln. unchanqed. by 
e.ffecti v e c>.n ti i nt=lamrr.a tory doses o£ cr:'{oQ:eni .n'?. "' 
dd . .. a - J. -;:J.on, u nl ike ste roidal 
C'iryogeni ne d o ,::: s not. redL:ce a.dren<·).J. s:i.z.e o:c produce 
t hymolys l s o n repeate d adm:i.ni s tratio !". . 
::.:r yoge ni!'le h ils llE:en .sLcwn t.o pos::::<~::;s a n'.:m't.:.er o.f 
.~roperties j_n corr.rno~l vd t.h c l5_nicr~l1y ~_;~. el'uJ. aTi:irh e;Jma'!::ic 
d rugs such as phen y l bu i:azor:e , ~.ndo:neth ac:Ln and asp:Lrin . 
It. i s effect:.v e i n s u ppress i ng vc.L"ious j_nfl amma t o:r:y 
rna.n5_:f e s ":ations of ad juvant-induced po l yarthri t..:is in t he 
rat a n d i nhibi t s ul t raviol et-indu.r:::ed e!:'ythema in ·the 
gu i nea pig . Ex periments i n ~1ich card iovascular r esponses 
indicated t."Bt the inhili i t o r y e:r-fec ts on edema for ma tion 
er-e ur1~d.kely t o b e due t o hy po t e nsion . Th e p r e s ent study 
has c.l s o :>hown cryogen i ne t o be e s sentia l l y devoi d of 
ganglioni c a c t ivi ty . ~-Jhile the a n t iinfl ammat ory effic acy 
of cryoge n ine do es not a p pear to b e r e l ated t o peri pheral 
neurotropic activity , its action may be me d ia ted , at least 
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